Circulating lncRNAs associated occurrence colorectal cancer progression.Screening potential biomarker (CRC) improve early detection. The aim study investigate circulating cell-free long non-coding RNAs (lncRNA) biomarkers CRC. In study, applied lncRNA microarray screen CRC multi-stage validation risk score formula We discovered three lncRNA, XLOC_006844, LOC152578 XLOC_000303, up-regulated comparing cancer-free controls merged area curve (AUC) training set 0.919 0.975. tumorigenesis prediction future. Decreased expression noncoding RNA AC096655.1-002 gastric clinical significance.Long (lncRNAs) newfound greater 200 nucleotides length. They emerged major players governing fundamental biological processes. However, level significances well understood. To cancer, real-time reverse transcriptase-polymerase chain reaction conducted. Then, association AC096655.1-002, tissues clinicopathological features patients analyzed. Receiver operating characteristic (ROC) constructed evaluate diagnostic values. downregulated compared paired adjacent non-tumorous (P &lt; 0.001). Its correlated lymph node metastasis 0.001), distant tumor-node-metastasis stages differentiation = 0.030). ROC 0.731. For detection remarkable improvement serum carcinoembryonic antigen. These indicated diagnosis carcinoma. lncRNA-MIAT regulates microvascular dysfunction functioning competing endogenous RNA.RATIONALE: Pathological angiogenesis critical component diseases, ocular disorders, cancers, atherosclerosis. It caused abnormal activity processes, cell proliferation, motility, immune, inflammation response. Long regulators role diabetes mellitus-induced unknown.OBJECTIVE: elucidate lncRNA-myocardial infarction-associated transcript (MIAT) involved dysfunction.METHODS AND RESULTS: Using quantitative polymerase reaction, demonstrated increased diabetic retinas endothelial cells cultured high glucose medium. Visual electrophysiology examination, TUNEL staining, retinal trypsin digestion, vascular permeability assay, vitro studies revealed MIAT knockdown ameliorated vivo, inhibited migration, tube formation vitro. Bioinformatics analysis, luciferase immunoprecipitation, functioned RNA, formed feedback loop growth factor miR-150-5p regulate function.CONCLUSIONS: This highlights involvement pathological facilitates development lncRNA-directed diagnostics therapeutics neovascular diseases. ANRIL proliferation human two- three-dimensional culture.ANRIL transcribed INK4 locus encodes tumor suppressor genes, p15, p16, ARF. Previous represses p15 positively pRB pathway, leading repression cellular senescence normal fibroblasts. Here report HCT116 culture. Silencing transfection small interfering retrovirally produced hairpin reduced depleted arrested S phase cycle. Notably, silencing result activation locus. culture p15/p16-pRB pathway-independent manner. Malat1 upregulated signalling PERK axis unfolded protein response flavivirus infection.Flavivirus infection host death initiation (UPR). UPR initiated ER-membrane resident sensors, PERK, IRE1α ATF6, inactive ER-chaperone GRP78. Activation precedes molecular changes restore homeostasis eventually initiate apoptosis. involve influencing function multiple genes transcriptional post-transcriptional post-translational mechanisms. Transcriptional control includes transcription cascades, influence cognate gene expression. over-expressed oncogenic cycle survival. report, time flaviviruses, activate cells. temporal kinetics restricted points. Further, activated pharmacological inducer UPR, degree. drugs inhibit demonstrate activates expression, mechanism. knowledge, pathway regulating lncRNA. Altered genotoxic stress-induced glioma cells.Long (lncRNAs), class genome. Emerging evidence suggests modulating aspects biology, including external stimuli DNA damage. No data apoptosis and/or necrosis detected change specific candidate (neat1, GAS5, TUG1, BC200, Malat1, MEG3, MIR155HG, PAR5, ST7OT1) damage-induced lines (U251 U87) doxorubicin (DOX) resveratrol (RES). pattern induced dose DOX. Our reveal patterns distinct sets expressed DNA-damaging agent-specific. Generally, MEG3 ST7OT1 agents. induction GAS5 clearly DOX-induced apoptosis, up-regulation neat1 MIR155HG RES-induced lines. BC200 regulated DOX conclusion, findings regulation process defense HULC promotes liver up-regulating sphingosine kinase 1 (SPHK1).Highly (HULC) (lncRNA). (SPHK1), angiogenesis. Levels levels SPHK1 product, sphingosine-1-phosphate (S1P), HCC samples. hepatoma Chicken chorioallantoic membrane (CAM) assays si-SPHK1 remarkably blocked HULC-enhanced Mechanistically, promoter E2F1. Chromatin immunoprecipitation (ChIP) electrophoretic mobility shift assay (EMSA) E2F1 capable binding element promoter. tissues. Intriguingly, sequestered miR-107, targeted mRNA 3'UTR, complementary base pairing. Functionally, abolished vivo. Taken together, conclude miR-107/E2F1/SPHK1 signaling. finding insights mechanism Colon Cancer Associated Transcript-1 (CCAT1) Expression Adenocarcinoma Stomach.BACKGROUND: functional roles biology dys-regulated tumors. Transcript -1 colon cancer. determine CCAT1 carcinoma (GC).METHODS: Tissue samples undergoing resection (n=19). patient, tissue appearing mucosa taken. Normal morbidly obese patients, laparoscopic sleeve gastrectomy served A (AGS) positive control. extracted analyzed real time-PCR (qRT-PCR).RESULTS: Low identified [mean Relative Quantity (RQ) 1.95±0.4]. AGS elevated (RQ=8.02). 10.8 fold higher GC negative group (RQ=21.1±5 vs. RQ=1.95±0.4, respectively, p&lt;0.001). Interestingly, overexpressed (RQ 15.25±2 Tissues recurrent cases highest 88.8±31; stage (T4- 36.4±15, T3- 16.1±6, T2- 4.7±1), reach statistical significance (p=0.2). There difference intestinal diffuse type (RQ=22.4±7 22.4±16, p=0.9). Within samples, observed helicobacter pylori (RQ= 2.4±0.9 0.93±0.2, p=0.13).CONCLUSION: serve bio-marker surveillance. Small nucleolar responses directly irradiated bystander cells.The communicate unirradiated induce phenomenon effect. nature signal impacts remains discovered. Examination lead identification pathways underlying Apart microRNAs, (ncRNA) monitored (snoRNAs) participate variety functions, gain insight lymphoblasts TK6 medium exchanged model system examine ncRNA alterations. snoRNA SNHG1 SNHG4 repressed SNHG5 SNHG11 lower MALAT1, MATR3, SRA1, SOX2OT RMST indicate modulated Linc00963: novel, transition prostate androgen-dependence androgen-independence.Whole genome transcriptomic analyses large number functions. functions mechanisms (PCa) progression virulent androgen-independent (AI) form remain elusive. Herein, investigated profiles indolent, androgen-dependent (AD) LNCaP aggressive metastatic, AI C4-2 technology. differentially technology cis trans find target genes. putative targets evaluated reverse-transcription (qRT-PCR). linc00963 migration invasion strategy MTT, flow cytometric analysis transwell chamber assays. (n=134) (FDR&lt;0.001 change≥2) Linc00963 qRT-PCR. Knockdown attenuated ability, EGFR phosphorylation AKT, promoted signaling pathway. TARID directs demethylation TCF21 GADD45A.DNA methylation dynamic reversible governs disease. Several examples active documented, involving genome-wide gene-specific demethylation. How demethylating enzymes genomic loci unknown. antisense termed (for inducing demethylation), interacts GADD45A (growth arrest DNA-damage-inducible, alpha), regulator turn recruits thymine-DNA glycosylase excision repair-mediated oxidation 5-methylcytosine 5-hydroxymethylcytosine ten-eleven translocation methylcytosine dioxygenase proteins. lncRNAs, serving address label GADD45A-mediated HBx-related DBH-AS1 survival activating MAPK hepatocellular carcinoma.Accumulating supports hepatitis B virus (HBx) pathogenesis (HBV)-induced (HCC), entirely clear. Here, novel HBx-mediated hepatocarcinogenesis. surface antigen (HBsAg) size transgenic enhanced tumorigenesis, short inhibition proliferation. overexpression accelerating G1/S G2/M concomitantly upregulation CDK6, CCND1, CCNE1 downregulation p21 p27. starvation-induced contrast, suppressed opposite effects. Furthermore, provide HBx markedly down-regulated p53. Thus, concluded inactivated p53, consequently promote HCC. acts oncogene Characterization SCAL1, cigarette smoke lung lines.The incidence diseases increasing. ultimately unclear. describes extract (CSE) vivo numerous cancer-associated lncRNA-1 (SCAL1). located chromosome 5, initial sequencing reveals exons introns. SCAL1 transcriptionally nuclear erythroid 2-related (NRF2), determined small, (siRNA) NRF2 kelch-like ECH-associated (KEAP1). erythroid-derived 2 (NF-E2) motif region activation. siRNA bronchial epithelial potentiation cytotoxicity CSE Altogether, identify intriguing downstream mediate oxidative stress protection airway TUG1 blood-tumor barrier targeting miR-144.Blood-tumor (BTB) limits delivery chemotherapeutic agent brain play regulatory biologic processes BTB LncRNA (taurine 1) highly co-cultured (GEC) permeability, tight junction proteins ZO-1, occludin, claudin-5. Both bioinformatics reporter influenced miR-144. Heat shock (HSF2), heat family, defined direct HSF2 activities interacted promoters claudin-5 GECs. miR-144 reducing EC HSF2. represent future therapeutic enhancing permeability. Co‑expression carbamoyl‑phosphate synthase 1 gene and non‑coding correlates poor prognosis intrahepatic cholangiocarcinoma.The rates malignancy recurrence cholangiocarcinoma (ICC) difficult diagnose assess ICC clinic lack biomarkers. addition, reported types reported. current abnormally ICC. global measured analysis. Carbamoyl‑phosphate (CPS1) CPS1 intronic transcript 1 (CPS1‑IT1) CPS1‑IT1 31 tissue effects ICC‑9810 cell measured. respect status co‑upregulated non‑cancerous andor ICC‑9810 cells. Additionally, relative values 4 comparisons low differences international normalized ratio (P=0.048), total (P=0.049), indirect bilirubin (P=0.025), alkaline phosphatase (P=0.003) disease‑free (P=0.034). differential trends CA19‑9 (P=0.068), globulin (P=0.052) (P=0.066). lymphatic (P=0.045), carbohydrate antigen 19‑9 (P=0.044), (P=0.026), non‑significant (P=0.085). promoting rates. prognostic indicators profile analysis.BACKGROUND: Thousands mammalian genomes. subset pervasive broad range Aberrant cancers. order explore (HCC) oncogenesis, performed 3 pairs non-tumor (NT) microarray.METHODOLOGY: Differentially mRNAs 33,045 30,215 coding transcripts. Bioinformatic (gene ontology, network analysis) mRNAs. By qRT-PCR nineteen tissues, aberrantly NT consistent data.CONCLUSIONS: 214 338 (Fold Change ≥2.0, P&lt;0.05 FDR &lt;0.05) lncRNA-mRNA co-expression constructed, predicting lncRNAs. BC017743, ENST00000395084, NR_026591, NR_015378 NR_024284 up-regulated, NR_027151, AK056988 uc003yqb.1 nearby changed, series hepatocarcinoma pathogenesis. SP1-induced TINCR KLF2 stability cancer.The aberrant squamous carcinomas. (GC), contribute oncogenesis progression. SP1. colony formation, tumorigenicity promotion, growth, documented SGC7901 BGC823 Mechanistic bind STAU1 (staufen1) protein, cyclin-dependent CDKN1A/P21 CDKN2B/P15 Together, contributes constitute Regulation Emx2 transcripts murine cortico-cerebral precursors.BACKGROUND: embryonic intermediate mesoderm central nervous (CNS). implicated cerebral cortex development, morphogenetic field specification, arealization, precursor lamination. Four Emx2-associated urogenital system; them, Emx2OS, adult brain. Until now, however, Emx2OS developing CNS.METHODOLOGY/PRINCIPAL FINDINGS: RT-PCR situ hybridization, reconstructed CNS, paying special attention cortex. CNS structures expressing Emx2. cortex, detectable periventricular precursors, sense transcript, peaked newly born post-mitotic neurons transcript. integrating lentiviral delivery, RNAi, TetON technology, morpholino-mediated knock-down, drug-induced perturbation RT-PCR, addressed Ex2 regulation, primary cultures. that, cortical precursors neuronal progenies, down-regulation partner, Dicer-promoted delivered rhombo-spinal stimulates ectopic Emx2, knock-out dramatically impairs transcription. reciprocal Emx2/Emx2OS sustain locus.CONCLUSIONS/SIGNIFICANCE: developmental key patterning, complex multilevel prototype method overexpressing single introducing additional copies Identification clear renal carcinoma.BACKGROUND: carcinogenesis; knowledge rudimental. As basis aimed (ccRCC) tissue.RESULTS: Microarray experiments 32,183 belonging 17,512 15 corresponding malignant Validation PCR 55 ccRCC 52 specimens. Computational lncRNA-microRNA (MiRTarget2) lncRNA-protein (catRAPID omics) interactions. 1,308 dysregulated (expression &gt;2-fold; upregulated: 568, downregulated: 740) tissue. Among these, validated PCR: lnc-BMP2-2 (mean change: 37-fold), lnc-CPN2-1 (13-fold), lnc-FZD1-2 (9-fold), lnc-ITPR2-3 (15-fold), lnc-SLC30A4-1 lnc-SPAM1-6 (10-fold) ccRCC, lnc-ACACA-1 (135-fold), lnc-FOXG1-2 (19-fold), lnc-LCP2-2 (2-fold), lnc-RP3-368B9 lnc-TTC34-3 (314-fold) downregulated. correlation clinical-pathological parameters. RNA-protein networks splicing, binding, transport, localization, processing RNA. (siRNA)-mediated proliferation.CONCLUSIONS: Inducing PCAT-1 bladder cancer.Long Prostate (PCAT-1) hypothesized urothelium. Cell (shRNA)-transfected T24 5637 plays treating CCDC26, myeloid leukemia KIT expression.BACKGROUND: Accumulating childhood acute (AML) copy altered AML patients.RESULTS: CCDC26 abundant fraction K562 (KD) (shRNAs), KD clones, 1% level, isolated. included suppression intron-containing (the mRNA), indicating (TGS), suppression, occurring. shRNA splice variants variant, TGS. Growth clones non-KD media concentrations. concentrations periods withdrawal clones. screening tyrosine receptor, KIT, hyperactive mutations AML. Treatment ISCK03, KIT-specific inhibitor, eliminated absence serum.CONCLUSIONS: inhibitor effective treatment forms altered. LINC01296 cancer.Colorectal (CRC), currently fourth deaths worldwide. Recent robust refine conventional staging predict outcomes patients. datasets (GSE24549, GSE24550, GSE35834, GSE50421, GSE31737) probe reannotation classification pipeline. Twenty-five tumor-adjacent 25 LINC01296, LINC00152, FIRRE better (P &lt; 0.05), suggesting prognosis. Multivariate independent predictor patients' test GSE24550) (P = 0.001) (GSE39582) (P = 0.027). Time, ataxia telangiectasia mutated (ATM) dependency ionizing radiation exposure.Studies proved defining action identifying exposure susceptibility. full involves epigenetic triggered modifications microRNAs (miRNAs) fully characterized. understanding radiation, simultaneously ten protein-coding 19 miRNAs time- dose-dependent manner stimulated T lymphocytes healthy donors (C1 C2) patient (AT), characterized radiosensitivity disorder. After Gy X irradiation, points ranging min 24 postirradiation. majority responded rapidly exposure, peak (CDKN1A, SESN1, ATF3, MDM2, PUMA GADD45A) (CCNB1) occurring 2-3 postirradiation, DDB2, FDXR CCNG1 slower reaching 5 h. modification miR-34a-5p miR-182-5p, late threefold Differences miR-182-5p detected: C2, reached plateau-phase Gy, C1, maximum decreased doses. studied, TP53TG1 weak up-regulation, 1.5-fold exposure. Conversely, FAS-AS1 fivefold irradiation. allows discrimination AT longer postirradiation although, interestingly, linear studied point. responsive dose- time-dependent best ATM-dependent fashion lymphocytes. Development Noncoding RNA-Based Strategies Modulate Vascularization.BACKGROUND: ribonucleic acids subclass angiogenic studied.OBJECTIVES: authors hypoxia-sensitive next-generation acid approaches. characteristics in vitro ex vivo.METHODS: Ribonucleic microarray-derived hypoxia. confirmed strong hypoxia-dependent intergenic lncRNAs: LINC00323 MIR503HG.RESULTS: led defects, GATA2. Endothelial loss hypoxia-driven impaired cell-cycle capillary formation. structural integrity ex vivo pluripotent stem cell-based engineered heart tissue.CONCLUSIONS: atlas biology. LncRNAs hold great promise cardiovascular MIR31HG emerging disorder MIR31HG, 9p21.3 2166 bp length, breast invasion. documented. larger advanced stage. Patients over-expression (GC) partly Novel RP11-119F7.4 dysregulation subsequently molecules Total 96 addition matched (NATs). Following transcription, receiver RP11-119F7.4. NATs (P&lt;0.001) macroscopic (P=0.041) Lauren grade (P=0.020). 0.637 (P&lt;0.001). statistically carcinogenesis prove BRAF-Activated Modulates Papillary Thyroid Carcinoma Proliferation Regulating Stimulating Hormone Receptor.PURPOSE: demonstrated. thyroid unknown.MATERIALS METHODS: BRAF-activated (BANCR), papillary susceptibility (PTCSC3), mitogen-activated (NAMA), study.RESULTS: Of (BANCR, PTCSC3, NAMA), BANCR PTCSC3 NAMA (PTC) BANCR-knockdown PTC-derived (IHH-4) stimulating hormone receptor (TSHR). G0/G1 cyclin D1. enriched polycomb enhancer zeste homolog (EZH2), chromatin recruitment EZH2, TSHR.CONCLUSION: PTC D1 TSHR. DLX6-AS1 adenocarcinoma.BACKGROUND: Lung adenocarcinoma (LAC), histological non-small (NSCLC), displayed increasing mortality approaches limited. Dysregulation cancers LAC. vertify LAC.METHODS: ( PCR) 72 LAC Western blotting verify DLX6 (distal-less homeobox 6) expression.RESULTS: 272 635 (P&lt; 0.05). closed (P = 0.004) TNM (P = 0.033). si-LncRNA NC (negative control) Blank groups.CONCLUSIONS: High Down-regulation levels. SNHG3 carcinoma.Long disease, (SNHG3) noncancerous 51 (qRT-PCR; P &lt; 0.001), cohorts Genome Atlas (TCGA) Oncomine databases (P &lt; 0.0001 P = 0.0325, respectively). 144 paraffin-embedded specimens hybridization (ISH). (P = 0.003), portal vein thrombus (PVTT; P = 0.014), relapse (P = 0.038). (OS; P &lt; 0.0001), recurrence-free (RFS; P = 0.006), disease-free (DFS; P &lt; 0.0001). More importantly, multivariate (P &lt; 0.001). MRUL ABCB1 multidrug-resistant sublines.Multidrug resistance (MDR) common chemotherapy failure treatment; carcinogenesis, MDR (MDR-related lncRNA), 400 kb (ATP-binding cassette, subfamily B, member 1), sublines, SGC7901/ADR SGC7901/VCR. negatively treated SGC7901/VCR accumulation, (Adriamycin [ADR]) release presence ADR vincristine. Moreover, depletion Heterologous affect orientation- position-independent phenotype sublines. let-7 sponge.BACKGROUND: deregulated (HCC).METHODS: 66 pair-matched hepatic tested PCR. assessed computational sites conducted search CCAT1. combined assay.RESULTS: Up-regulation size, invasion, AFP sponge let-7, antagonizes leads de-repression HMGA2 c-Myc. dependent competitively let-7.CONCLUSIONS: pivotal sponge, implicate application Striatal Abhd11os neuroprotective N-terminal fragment mutant huntingtin vivo.A products striatum ill-defined age-dependent neurodegenerative striatum, Huntington disease (HD). focused Abhd11os, (called ABHD11-AS1 human) mouse striatum. confirm despite open reading frames (ORFs) sequence, translated peptide living models HD. mice vectors encoding Abhd11os. Results produces neuroprotection huntingtin, protoxic. striatal vulnerability emphasizes crucial Differentiation mammary tumors reduction loss.Genome-wide thousands (lncRNAs). (metastasis-associated genetic systemic oligonucleotides (ASOs) MMTV (mouse virus)-PyMT accompanied cystic metastasis. branching morphogenesis MMTV-PyMT- Her2/neu-amplified organoids, adhesion, migration. At alterations splicing protumorigenic pathways. represents exciting target, ASOs therapy inhibiting Detection nuclear-enriched autosomal (NEAT1) peripheral blood HIV-1-infected patients.OBJECTIVES: HIV-1 extensively studied. (MALAT1), mononuclear (PBMCs) plasma patients.METHODS: Fifty-nine 21 recruited 31 antiretroviral (HAART)-naïve 28 receiving HAART year undetectable viral loads. PBMCs plasma, NEAT1 MALAT1 reaction.RESULTS: HAART-naïve HAART. infected CD4 T-cell count.CONCLUSIONS: interact infection. gallbladder modulation miRNA-218-5p.Protein-coding account ~2% genome, vast (ncRNAs) ncRNAs growing volume literature proposed factors transcript-1 (CCAT1), exerts Recently, cross-talk shared (miRNAs). competitive bioavailability targets, imposing posttranscriptional regulation. (GBC) downregulated, miRNA-218-5p Bmi1 'spongeing' miRNA-218-5p. invasiveness GBC cells, miRNA-218-5p-mediated Bmi1. driver malignancy, Prognostic widespread elucidated. measure HCC.METHODS: examined 117 real-time-PCR parameters.RESULTS: (P&lt;0.05). Up-regulated (P&lt;0.05), Kaplan-Meier Cox regression rate patients.CONCLUSIONS: suggested parameters Circulation carcinoma.BACKGROUND &amp; AIMS: Alpha Fetal Protein (AFP) traditional Hepatocellular clinically, specificity AFP, inferior. new, minimally invasive necessary.METHODS: validation.RESULTS: RP11-160H22.5, XLOC_014172 LOC149086, 0.999 0.896. LOC149086 AUC 0.900 0.934. Besides, presented operation, secondary hematogenous metastasis.CONCLUSIONS: GAS5: marker glucocorticoid response.Glucocorticoids (GCs) exert cytoplasm (GR) encoded NR3C1 gene. GR autoregulation intragenic sequences called GRE-like elements, contained arrest-specific (GAS5) suppressing activity. antiproliferative methylprednisolone correlate individual sensitivity GCs. Subjects responders GCs comparison good responders. alter effectiveness, autoregulation. Signatures Adolescent Idiopathic Scoliosis.PURPOSE: idiopathic scoliosis (AIS), pediatric spinal deformity, considered Causing AIS designed AIS.METHODS: comprehensive children Agilent + Array V3.0 microarray. PCR.RESULTS: 139 546 GO Pathway bone mineralization, neuromuscular junction, skeletal morphogenesis, nucleotide nucleic metabolism, (ENST00000440778.1, ENST00000602322.1, ENST00000414894.1, TCONS_00028768) grouped age, height, classification, severity scoliosis, Risser grade.CONCLUSIONS: demonstrates AIS, features. helpful pathogenesis, treatment, AIS. derived CD244 epigenetically CD8+ immune tuberculosis infection.Molecular cell-inhibitory (TB) TB up-regulates signaling-associated CD8(+) blockade enhances production IFN-γ TNF-α. expression/signaling (lncRNA)-BC050410 [named lncRNA-AS-GSTT1(1-72) lncRNA-CD244] CD244(+)CD8(+) subpopulation. drives lncRNA-CD244 sustaining permissive state recruiting (EZH2) infg/tnfa promoters, mediates H3K27 trimethylation repressive states inhibits IFN-γ/TNF-α Such reversed knock lncRNA-CD244. adoptive transfer lncRNA-CD244-depressed Mycobacterium (MTB)-infected MTB pathology lncRNA-CD244-expressed controls. work uncovers unidentified Increased H19 angiogenesis, stemness glioblastoma cells.OBJECT carcinogenesis. object METHODS Glioblastoma nontumor 30 glioblastoma. reaction. commercially (U87 U373). Matrigel assay. neurosphere xenograft model. RESULTS subsequent investigations, CD133(+) Finally, stable CONCLUSIONS stemness, intervening 00320 brain-specific white matter.Pervasive diverse array (ncRNAs). One ncRNAs, (lincRNAs) thought contributor organism complexity. heterogeneous make-up rich source lincRNAs; lincRNAs completing (RNA-Seq) frontal linc00320 matter grey atrophy (MSA) regions MSA process. full-length primates, improved connectivity cognition. HepG2 cholesterol metabolism.BACKGROUND: Green tea metabolism animal studies, contributing benefits epigallocatechin-3-gallate (EGCG) metabolism.METHODS: Microarrays green polyphenol(-)-epigallocatechin gallate (HepG2) hepatocytes EGCG bioinformatic predicted relationships. interference metabolism.RESULTS: 285 changed treatment. mRNA. particular, AT102202 mRNA-3-hydroxy-3-methylglutaryl coenzyme reductase (HMGCR) identified. technique, HMGCR AT102202. HepG2, scrambled 0.05).CONCLUSIONS: metabolism. deregulation tongue tumorigenic malignancies. (SCC).METHODS: Functional carried ncFANs. Real-time validate lncRNAs.RESULTS: annotation algorithm ncFANs, 8 Lnc-PPP2R4-5, lnc-SPRR2D-1, lnc-MAN1A2-1, lnc-FAM46A-1, lnc-MBL2-4:1, lnc-MBL2-4:3 microdissected SCC comparison, lnc-AL355149.1-1 lnc-STXBP5-1 downregulation. T-stage 5-fluorouracil paclitaxel reserve noticed cisplatin-resistant cells.CONCLUSIONS: existing dataset. nodal SCC. LINC01133 predicts survival.Lung (LAD) (LSCC) LSCC differs greatly LAD aspects. tissue-specific mining Affymetrix HG-U133 Plus 2.0 1646 LINC01133, largest RNAs. Quantitative (PCR) (increasing 6.4, P &lt; 0.01) shorter (hazard ratio = 2.383; 95 % confidence interval 1.023-5.547, P = 0.044). Wound-healing silence ability line. non-protein POU3F3 esophageal cells.BACKGROUND mammals studies. Many functional, (ESCC).METHODS: 26 conserved ESCC surrounding 182 collected tylectomy First Affiliate Hospital Soochow University 2001 2009; 178 Guangzhou Medical 2002 2009. LincRNAs knocked Eca-109 TE-1 cells.RESULTS: lincRNA (linc-POU3F3) neighboring assays, linc-POU3F3 EZH2 messenger (mRNA). Overexpression colonies, mRNA, CpG islands densely hypermethylated linc-POU3F3; linc-POU3F3. Pharmacologic methyltransferase (DNMT)1, DNMT3A, DNMT3B POU3F3. slowly interacting POU3F3, factor. Attenuated BACE1 cleave amyloid BACE1‑AS expression.Although numbers detected, clarified. β‑secretase‑1 (BACE1‑AS) Alzheimer's rapid feed‑forward β‑secretase, AD development. senile plaque (SP) SH‑SY5Y established synthetic β‑protein (Aβ) 1‑42 model, siRNA‑mediated attenuate (BACE1) (APP) reduce Aβ1‑42 oligomers investigated. MTT exogenous APP‑related SP western blot Aβ1‑40 group, marked decrease Ki‑67 day six. RNase (RPA) northern APP‑cleaving enzyme BACE1, duplexes Downregulation attenuation APP delayed prevalence mellitus.BACKGROUND: Diabetes mellitus (DM), metabolic fasting Type DM onset diabetes. linked diseases.METHODS: Serum participating veterans JAH VA deposited Research Biospecimen Repository. two-stage T2DM. Initially screened non-diabetic individuals arrays. Next, optimal cutoff DM.RESULTS: cohort US military veterans. equal 10. qPCR absolute GAS5 &lt; 10 ng/μl twelve times odds (Exact Odds Ratio [OR] = 11.79 (95% CI: 3.97, 37.26), p &lt; 0.001). Analysis 0.81 85.1% 67.3% distinguishing subjects. predictive 71.4%.CONCLUSION: T2DM.GENERAL SIGNIFICANCE: Assessment offers accuracy at-risk UCA1 induces non-T790M acquired EGFR-TKIs AKT/mTOR EGFR-mutant (urothelial epidermal inhibitors (EGFR-TKIs) (NSCLC). EGFR-TKIs. Over-expression progression-free (PFS) [13.0 8.5 months, P 0.01] respond relationship T790M mutation (10.5 12.0 0.778), (19.0 9.0 0.023). restored gefitinib resistant epithelial-mesenchymal (EMT). mTOR UCA1-expressing PC9/R. Inhibiting UCA1, difference. PFS subgroup mutation. EMT. LncRNA-UCA1 miR-193a-3p.Recently, urothelial carcinoma-associated (UCA1) entitles, tightly (NSCLC) NSCLC Higher poorer time, enhanced, mechanistic investigations miR-193a-3p ERBB4 miR-193a-3p. Overall, NSCLC, acting mechanistically upregulating Antisense HIF1A-AS2 Is Upregulated Gastric Poor Prognosis.BACKGROUND: hypoxia-inducible 1alpha RNA-2 (HIF1A-AS2) nonpapillary clear-cell carcinomas progression.AIM: cells.MATERIALS detect Area (ROC(AUC)) HIF1A-AS2. HIF1A-AS2, vitro, nude vivo.RESULTS: tumorous 0.008), 0.016), 0.042), ROC(AUC) 0.673 (95 CI 0.596-0.744, vivo.CONCLUSIONS: GC. lnc-ZNF180-2 carcinoma.Clear decipher re-evaluated published profiling data. An 49 allowed localized ccRCC. (lnc-ACO1625, lnc-CYP4A22-2/3, lnc-PEAK1.1-1, lnc-PCYOX1L, lnc-VCAN-1, lnc-ZNF180-2) interest 50 renal, 57 45 tissue, increase survival, cancer-specific lnc-CYP4A22-2/3 quantification outcome nephrectomy. Pint connects p53 Polycomb 2.BACKGROUND: core wiring preservation homeostasis. Only (lincRNAs). pathway.RESULTS: characterize named (p53 transcript). aubiquitously finely TGF-b, (PRC2), required PRC2 tri-methylation repression. ortholog (PINT), presents suggestive analogies lincRNA. PINT ortholog, tumors, suppressor.CONCLUSIONS: autoregulatory PRC2. orthologs, PVT1 patients.PVT1, maps 8q24, amplification-associated powerful types. PVT1, Between 2003 2012, transcription-quantitative cohorts: Cohort one, 58 samples; 2, transplant cancerous non-cancerous (cohort P=0.0016; two, P=0.0274). α-fetoprotein (P=0.011) (P=0.004). exhibited (P=0.021), (P=0.042; hazard ratio, 1.653). target. mitosis-associated MA-linc1, sensitizes Paclitaxel.Long tumorigenesis. growth. Inhibition MA-linc1 alters distribution, G1 concomitant cycle, G2/M, M phase. Accordingly, exit mitotic block. repress gene, Purα, deleted Knock Purα partially rescues exit. agreement phase, apoptotic antimitotic drug, Paclitaxel enhancement rescued knockdown. patients.Taken CRNDE miR-186.The Colorectal neoplasia (CRNDE) neoplasia, solid (GSCs) miR-186 GSCs. exerted GSCs And XIAP PAK7 it. binded 3'UTR region, caspase 3, BAD, MARK2. minimum tumor-bearing miR-186. played regarded therapy. Deletion GNAS pseudohypoparathyroidism Ib biparental defects cis.CONTEXT: alpha-subunit stimulatory G imprinted maternally NESP55 paternally XLalphas, antisense, A/B Most (PHP-Ib) exhibit imprinting maternal allele, reduce/abolish Gsalpha proximal tubules PTH.OBJECTIVE: objective define defect unreported family dominant PHP-Ib.DESIGN SETTING: Analyses urine chemistries lymphoblastoid-derived tertiary hospital laboratory.PATIENTS: Affected muscle weakness paresthesia hypocalcemia, hyperphosphatemia, PTH. Obligate carriers obvious abnormality mineral ion homeostasis.RESULTS: 4.2-kb microdeletion obligate carriers, ablating preserving exon. On transmission, deletion imprints, partial methylation, PTH resistance. Paternal transmission cis, methylation.CONCLUSIONS: unique cis-acting telomeric exon alleles. PHP imprinting. Biological FTX purpose analyze (CRC). 35 187 correlations examined. Univariate Non-coding phenotypes determined. grade, FTX. Therefore, Genome-wide Helicobacter pylori.Long misregulation pathogen rarely pathogenic bacterium gastritis, peptic ulcer mucosa-associated lymphoid lymphoma, H. pylori-induced nonoverlapping signatures pylori-infected bioassays. From data, 23 Five XLOC_004562, XLOC_005912, XLOC_000620, XLOC_004122, XLOC_014388, transcription-PCR, XLOC_004122 XLOC_014388 mucosal pylori-positive pylori, pylori-related EGOT cancer.Eosinophil granule ontogeny (EGOT) eosinophil 250 (P &lt; 0.001), (P = 0.022), (P = 0.020), Ki-67 (P = 0.017). worse (P = 0.040), public database. (HR = 1.857, CI = 1.032-3.340, P = 0.039). Integrated uterine leiomyomas.Global leiomyomas (ULMs) ULM ULMs explored. expressions interrogated interrelationship degree size. Further depending locations orientations. extended AK023096 chromatin-associated (CAR) Intergenic 10 leiomyomas. leiomyoma ADAM12 Aberrantly juice lncRNA-ABHD11-AS1 vital 173 130 benign lesion, dysplasia, premalignant lesions, collected. transcription-polymerase relationships minimal atrophic ulcers gender, stage, type, (CEA) marker, 71.4 %. Thanks origin juice, KLF2.BACKGROUND: cancer-related worldwide, indicates Taurine Gene (TUG1), 7.1-kb disregulated (ESCC). unclear.METHODS 77 (qPCR). Barcelona Clinic Liver (BCLC) SP1 epigeneticly Kruppel-like (KLF2) region.CONCLUSION: regulator, links endometrioid endometrial trithorax aberrations.BACKGROUND: Integrative (EEC) platforms distinguished subgroups. landscape charting EEC subgroups determining aggressiveness unknown.RESULTS: stringent criteria, 1,931 drivers integrative Unsupervised clustering categories: basal-like, luminal-like CTNNB1-enriched Basal-like (p 0.0001), 0.01), somatic trithorax-group (MLL, MLL2 MLL3); CBX2. contrast subgroup, progesterone (PGR) estrogen (ESR1) basal-like subgroup. Consistent enrichment CTNNB1 (69%), subgroup.MATERIALS RNAseq 191 available. modifying described clinico-genomic features.CONCLUSIONS: utility systematic characterization clinically annotated relevant highlight convergence aberrations polycomb- basal subtypes, providing rationale investigation setting. AC138128.1 cancer.It goal AC138128.1, association. 94 (NAT) constructed. NAT lines, BGC-823, HG27, SGC-7901 GES-1. 0.688. HOTAIR pancreatic ductal Wnt inhibitory 1.Pancreatic (PDAC) seriously radiotherapy HOX (HOTAIR) PDAC. PDAC (qRT-PCR), X-ray radiosensitivity, Counting Kit-8 (CCK-8) cytometry, respectively. (WIF-1) WIF-1 (n = 90) (HPDE) (n = 90). radiation. WIF-1. WIF-1, HOTAIR-WIF-1 radiotherapy. ADAMTS9-AS2 DNMT1 cells.Growing modulators origination ADAM metallopeptidase thrombospondin motif, 9 (ADAMTS9) (ADAMTS9-AS2), unknown function, ADAMTS9. gain-/loss-of-function reversely glioma. glioma, methyltransferase-1 (DNMT1). 5-aza-dC reactivated. HNF1A-AS1 oesophageal cells.OBJECTIVES: (EAC) progression.DESIGN: EACs RNA-sequencing (qRTPCR) EAC combination RNA-mediated relevance HNF1A-AS1, 10.6, p&lt;0.01). anchorage-independent S-phase entry, (p&lt;0.05). ontological preferentially assembly nucleosome, essential H19, finding, (p&lt;0.01).CONCLUSIONS: EAC. participates participation mediated, part, nucleosome induction. cardiac adenocarcinoma.BACKGROUND/AIMS: pervasively maintain Abnormal (GCA) With GCA interrogate level.METHODS: isolated non-cancerous, hybridized arraystar V2.0 chips probes representing 33,000 6 ontology(GO) investigation.RESULTS: corresponded 20 (p-value cut-off 0.05). GOs esenriched homeostasis.CONCLUSION: Notch-1 GAS5.BACKGROUND: Notch prevent exact signaling, explained.OBJECTIVE: original implications explain lnRNA Notch-1, cancer.METHOD: Thirty Affiliated Anhui (China) January 2006 study. 5-year Notch-1. Subsequently, Notch1-siRNA T47D, RSA5 CCK-8 T47D provided Interference 0.05), GAS5.CONCLUSION: GAS5. prognosis.Hox biomarker. (AML). marrow de novo AML-CR transcription-PCR hotair CCK, finally controls; HL-60 K562; NCCN group. stratification microarray.Dysregulation feature 3,324 2,120 (≥2-fold change). 110 groups (≥8-fold (TNXA, CTA-134P22.2, CTC-276P9.1 KRT19P3) selected confirmation (qPCR), tens construction network. Kyoto Encyclopedia Genes Genomes propanoate collection non-invasive markers. ESCC-related released circulation utilized monitor ESCC.METHODS: Ten (HOTAIR, AFAP1-AS1, 91H, PlncRNA1, SPRY4-IT1, ENST00000435885.1, XLOC_013104 ENST00000547963.1) differently four-stage exploratory hypothesis: (1) optimization accurately reproducibly serum; (2) evaluation (3) exploration vivo; (4) power ESCC.RESULTS: SPRY4-IT1 investigated, performance (AUC), 0.842; p &lt; 0.001; sensitivity, 72.8%; specificity, 89.4%). SCCA (AUC, 0.926, p &lt; 0.001, 85.7%; 81.4%). (80.8%).CONCLUSIONS: Plasma ESCC, efficient detection, screening. linc-MAF-4.Long system. 13 subsets sequencing-based (RNA-seq transcriptome reconstruction. 500 signatures. linc-MAF-4, TH1 helper inversely MAF, TH2-associated linc-MAF-4 skewed TH2 phenotype. long-distance interaction modifiers LSD1 EZH2; MAF modifiers. lymphocyte differentiation. apolipoprotein cluster RNA.Apolipoprotein A1 (APOA1) high-density lipoprotein (HDL) plasma. endogenously natural APOA1-AS, APOA1 in vivo. APOA1-AS APO cluster. ∼50 flanking modulate histone mark histone-modifying enzymes. Targeting monkey African monkeys. local modulatory manipulating RMEL3, BRAFV600E-associated PI3K melanoma.Previous RMEL3 melanoma. melanoma BRAFV600E. siRNA-mediated (95%) BRAFV600E Multiple TCGA experimentally confirmed. activators effectors pathways, FGF2, FGF3, DUSP6, ITGB3 GNG2. PTEN cyclin-Cdk p27, pAKT (T308), BRAF, (S807, S811) B1. Consistently, accumulation subG0/G1 asynchronously population. KLF4-KRT6/13 pathway.Long paly postoperative (PC) PC KLF4 PC3 loss-of-function subsequently, KRT6 KRT13. PC. partially, inactivation cascade. patients.Long entities glioma; results, closely 0.023), WHO 0.005), 0.011). curves unfavorable (OS) 0.002). OS chemoradiotherapy grade. III~IV conferred (stage 0.002, 0.000). Transcriptome suppressor.Esophageal Squamous (ESCC) past, extensive efforts customized RNA-seq ESCCs "ESCC-associated (ESCALs)", which, pattern. Also, ESCALs appeared (GSEA) half positively-or negatively-associated nuclear-retained Epist, generally esophagus, Epist metastasis, ESCC. Collectively, foundation targeting. LINC01207 adenocarcinoma.Lung differ help understand LSCC. project. 1207 (LINC01207) (5.78 increase, P&lt;0.05), (P&lt;0.05) (HR=2.53, P&lt;0.05). mediated LINC01207, A549 inhibited. percentage increased. lysine 27 Bad, pro-apoptotic developed transfected siRNA-LINC01207 weight smaller volume. summary, LSCC; P21 expression.Recent lncRNAs' misregulated nominated actors p15(INK4B), ATM-E2F1 previous miR99a miR449a advantage impair uncover PC9 conclusively associating lncRNA-driven Tissue-specific RNA-Seq evoked identifies adipose LincRNA cardiometabolic diseases.OBJECTIVE: Inappropriate innate immunity inflammatory disease-relevant tissues.APPROACH deep (&gt;500 filtered reads sample) low-dose experimental endotoxemia (lipopolysaccharide) human, replication separate (n=6), lincRNAs. adipocytes monocytes, humans, overlap signals traits. 4284 lincRNAs, ≈11% 22% 201 56 lipopolysaccharide adipose, lipopolysaccharide-lincRNAs replicated adipose. broader generalizability subject 7 monocytes cell-sources selective lipopolysaccharide-regulated linc-DMRT2 (P=0.002) linc-TP53I13 (P=0.01), humans. lipopolysaccharide-modulated polymorphisms traits.CONCLUSIONS: tissue-level, usual limited interrogation variations. TET3 stellate HIF1A-AS1.Activated Hepatic (HSCs) fibrosis lot dissect HSCs. douteux now. TET3, (TET) HSCs LX-2 TGF-β1. HSCs, interference. rise TET3. Meanwhile, IHC α-SMA HIF1A-AS1 hinted HIF1A-AS1. hypothesis, declining RNA-ncRuPAR cancer.In years, increasingly focused. ncRuPAR lncRNA; downregulating protease-activated receptor-1 (PAR-1), self-control 105 (qRT-PCR) immunohistochemical PAR-1 correlation; clinicopathologic PAR-1, areas. Duck's differentiation, EI scores PAR-1. (CI): 0.75-0.87); 8.34, measurement 97.14%, 65.87%, 82.86% Study RGMB-AS1 repulsive guidance molecule cancer.BACKGROUND: focuses present.METHODS: (RGMB) relations RGMB SPC-A-1 analysis.RESULTS: 571 cut-off: 5.0, P &lt; 0.05), 304 267 trend (P &lt; 0.05). Correlation RGMB-AS1and (R(2) = 0.590, P &lt; 0.05). While status, metastases Transfection RGMB-AS1, (P &lt; 0.05) groups.CONCLUSION: Studies correlated.VIRTUAL SLIDES: virtual slide(s) article here: http://www.diagnosticpathology.diagnomx.eu/vs/7911587521528276. CAI2, 9p21-embedded advanced-stage neuroblastoma.Neuroblastoma heterogeneity. p16 ARF, tumor-suppressor 9p21, commonly paradoxically neuroblastoma. γ undescribed CAI2 (CDKN2A/ARF Intron lncRNA). single-exon poly p16/ARF 3. intact 9p21 Concordant ARF neuroblastoma transformed serial passage dramatically. neuroblastomas neuroblastoma, independently MYCN amplification. high-risk outcomes, adjusted paradoxical offer Role maintaining smooth cells.BACKGROUND: (ASM) maintains proliferative airways, corticosteroids, airways mRNAs, species ASM corticosteroid, dexamethasone, fetal calf (FCS).METHODS: miRNA (including miR-150, -371-5p, -718, -940, -1181, -1207-5p, -1915, -3663-3p) dexamethasone FCS. actin cytoskeleton. pseudogenes, LINC00882, LINC00883, activator, c-MYC. propose (RP11-46A10.4, BCYRN1, LINC00882) 'sponges' (miR-150, -1207-5p).CONCLUSION: in-vitro ncRNAs. Their experimentation establish causality phenotype, asthma chronic obstructive pulmonary (COPD). ERIC E2F modulates damage.BACKGROUND: fate. death, suppressor, RB. retinoblastoma activity.RESULTS: XLOC 006942, ERIC, and, probably, E2F3. E2F1, E2F3 E2Fs. binds ERIC's E2F1-dependent E2F1-mediated damage drug Etoposide, Etoposide -induced apoptosis.CONCLUSIONS: E2Fs, restricts Association organ lupus erythematosus.INTRODUCTION: Despite physiological conditions, erythematosus (SLE)-related (ENST00000500949: linc0949, ENST00000500597: linc0597, ENST00000501992: linc1992, ENST00000523995: linc3995) SLE activity, damage, medical therapies.METHODS: 102 SLE, 54 rheumatoid arthritis (RA) 76 donors. Disease Systemic Lupus Erythematosus Activity Index 2000 (SLEDAI-2K) scores, International Collaborating Clinics/American College Rheumatology Damage Index.RESULTS: linc0949 linc0597 RA SLEDAI-2K (r = -0.329, P = 0.0007), complement C3 (r = 0.348, P = 0.0003). cumulative decreasing nephritis. expression.CONCLUSIONS: empirical diagnosis, SLE. AATBC suppresses lincRNA, AATBC. pT D1, CDK4, p18 phosphorylated Rb. intrinsic evidenced caspase-9 caspase-3. JNK NRF2. SP600125 achieved knockdown, confirming suppress pro-proliferation anti-apoptosis cell-enriched RNA.OBJECTIVE: paucity phenotypes.APPROACH (RNA-seq) coronary artery unannotated (Smooth migration/differentiation-associated NonCoding [SENCR]). Strand-specific amplification cDNA ends SENCR 5' FLI1 exists variants. fluorescence biochemical fractionation cytoplasmic observation, disclose Myocardin contractile promigratory Reverse Loss-of-function scratch wound Boyden support migration.CONCLUSIONS: cell-enriched, stabilize Loc554202 cleavage cascades.BACKGROUND: frequently Increasing 2166-bp 9p21.3, investigation.METHODS: Gain qRT-PCR, western-blotting immunohistochemistry apoptosis-related factors.RESULTS: pathologic hindered cascades.CONCLUSION: therapies. DANCR cancer.Despite advances long-term poor. anti-differentiation (lncRNA DANCR) 104 histologic (DFS) DFS PU.1-Regulated lnc-MC Controls Human Monocyte/Macrophage Interaction MicroRNA 199a-5p.Long monocyte/macrophage monocytic (lnc-MC) exhibits THP-1 CD34(+) hematopoietic stem/progenitor (HSPCs) PU.1. Gain- HSPCs. sequester microRNA 199a-5p (miR-199a-5p) alleviate activin 1B (ACVR1B), miR-199a-5p PU.1-dominant weakens lnc-MC. PU.1-regulated RNAs, miR-199a-5p, opposing process, PU.1, soaking releasing ACVR1B mechanism, comprising lnc-MC, ACVR1B, FENDRR fibronectin1 complexe (PRC2) found.METHOD: lines/tissues cells/adjacent Wound healing PCR, western-blot (FN1). Secreted matrix metalloproteinase (MMP) gelatin zymography deeper (p &lt; 0.001), (p = 0.001), (p = 0.007). Histone deacetylation FENDER FN1 MMP2/MMP9 expression.CONCLUSION: occurs CAHM, neoplasia.The CAHM (Colorectal HyperMethylated), LOC100526820, 6, hg19 chr6:163 834 097-163 834 982. lacks introns, QKI, protein. Deep bisulphite frequent hypermethylation methylation-specific (qMSP) threshold 5% 2/26 (8%), 17/21 adenomas (81%), 56/79 (71%). transcriptase-qPCR typically qMSP 220 colonoscopy-examined pg methylated mL 40/73 (55%) 3/73 (4%) subjects 5/74 (7%) neoplasia. frequency amount Methylated Toll-Like Receptor 3-Activated Mesenchymal Stem Cells.Mesenchymal (MSCs) possess immunomodulatory capacity lays toll-like receptors (TLR) MSC functions; wide TLR MSCs, 10.2% (1733 16967) 15.1% (1760 11632) (absolute fold-change ≥5 , ≤0.05) TLR3 MSCs. classes length distribution MSCs framework landscapes NRON NFAT-dependent proteins.A HIV/AIDS NEAT1, life profiled 90 disease-related (noncoding repressor Nuclear Factor Activated [NFAT]) complex; accessory Nef Vpu. Consequently, Vpu NFAT. NFAT LTR. NFAT, NRON. add repertoire HIV persistence. MALAT1/miR-1/slug radioresistance nasopharyngeal carcinoma.Recent (NPC) radioresistance. NPC sensitize (CSC) miR-1, slug miR-1. Taking observations consideration, CSC miR-1/slug axis, Sox2ot prognosis.BACKGROUND: contributions unknown.METHODS: 84 Survival Cox's proportional hazards invasion.RESULTS: knocking Extracellular vesicle-mediated ROR chemosensitivity cancer.Hepatocellular chemotherapy. TGFβ chemoresistance explored assessing contribution extracellular vesicle mediating TGFβ-dependent chemoresistance. sorafenib vesicles vesicles. Amongst lincRNA-ROR (linc-ROR), stress-responsive Incubation HCC-derived linc-ROR chemotherapy-induced recipient Sorafenib vesicles, cytotoxicity. Tumor-initiating express CD133 CD133+ limiting dilution showing that: (a) selectively enriches linc-RoR intercellular TGFβ; (b) chemoresistance; (c) linc-RoR-dependent tumor-initiating mediators response, enhance ZFAS1 CDK1 p53-dependent cancer.We 83 119 111 two-times 0.0001). (HCT116+/+, HCT116-/- DLD-1) showed, decreases G1-arrest Cyclin-dependent (CDK1) partner pull-down experiment immunoprecipitation. approach miR-590-3p, CDK1. silencing, B1 PARP main actions: (i) destabilization (ii) CDK1/cyclin interactions vimentin.Hepatocellular third (P&lt;0.010) thrombosis (P=0.001). (P=0.017). vimentin GAS5-pcDNA3.1-inhibition etiology cancer.Accumulating unclear role, NSCLC. (TNM) regional differentiating 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (mRNA) P15 pcDNA3.1-PVT1. promising laser micro-dissected archival FFPE specimens.OBJECTIVES: (AIS) step adenocarcinoma. elucidated challenges obtaining fresh analyses. Formalin fixation paraffin embedding (FFPE) storage. recently, working precluded technologies (RNA-seq), clarify isolation techniques laser-capture micro-dissection select histopathologically allowing researchers variations juxtaposed types.MATERIALS Utilizing alignment tools normal, markers progression.RESULTS: sequenced 18 generated average 198 sample. filtering, uniquely aligned represented 35% reads. consistently up- RT-qPCR proof principle.CONCLUSION: anticipate will lay groundwork AFAP1-AS1 carcinoma.Altered 12 epitheliums. filament RNA1 (AFAP1-AS1), capability. AFAP1 Proteomic GTPase members cytokeratin integrity. NPC. Two deletions overlapping FOXF1 unravel LINC01081 alveolar dysplasia misalignment veins.Position disruption cis-regulatory 40 loci; long-range veins (ACDMPV) mapping 0.3 Mb upstream 16q24.1. atypical late-onset ACDMPV, ∼1.5 removed 43% enhancer, leaving lung-specific intact. second severe neonatal-onset ∼194 disrupted LINC01081. arose 16, supporting notion lungs. RNAi-mediated knock-down fibroblasts ACDMPV. cervical miR-21.Recent unexplored. (MEG3), 108 FIGO stages, HR-HPV homo sapiens microRNA-21 (miR-21). miR-21-5p causing miR-21-5p, result, improves indicator survival.Sox2 (Sox2ot) (lncRNA), 3q26.33, amplified (SCCs). investigation. folds 53.01% (44/83). SCCs adenocarcinomas (ADCs) lung. (P=0.0053), implying HCC827 SK-MES-1, arrest, Reduced Cyclin Cdc2 observed. Importantly, reintroduction progressed restoration expressions. Trait Loci CARD8 Contributes Risk Infection-Related Cancers--Hepatocellular Cervical Cancer.Caspase domain (CARD8) coordinate adaptive virus-induced analyses, (SNPs) trait (eQTLs) CARD8. eQTLs SNPs case-control 1,300 HBV-positive 1,344 controls, 1,486 1,536 SNP (rs7248320) variant genotype rs7248320 [GG AA/GA: (OR) 1.28, 95% (CI) 1.03-1.61, 0.028 HCC; OR 1.34, 1.09-1.66, 0.006 cancer]. prominent premenopausal women. interactive multiplicative menopausal 0.018). virus-related Profile 5-Fluorouracil-Based Chemoradiation Resistance Cells.BACKGROUND: Preoperative (5-FU)-based standard locally develop chemoradiation (CRR). myriad Since 5-FU-based CRR unknown, study.MATERIALS concurrent HCT116. undertaken parental lines.RESULTS: total, 2,662 2,398 (KEGG) many, Jak- STAT, PI3K-Akt NF-kappa based genes.CONCLUSIONS: Changes LOC389641 increases E-cadherin TNFRSF10A-related manner.Long LOC389641, staging, LOC389641. inhibited, hindered. TNFRSF10A. Lastly, TNFRSF10A connection LOC389641and E-cadherin. lncRNA-AC130710 miR-129-5p associates prognosis.Long AC130710, gathered 78 AC130710 (RT-PCR). underling (P = 0.013), (P = 0.030), distal (P = 0.018). MGC-803 GES-1 Upregulation 34 (GC). (70.8%, p &lt; 0.01), (p = 0.024), (p = 0.003), (p = 0.032), (p = 0.293) (p = 0.125). node, reflect Adjuvant miR-203 ADAM9 HULC.MicroRNAs integrated programs level. miRNAs. (a disintegrin 9)/oncogenic (highly cancer) intriguingly, diminished miR-203-mediated antitumor suppressive Genomic combining profling.Recently, seldom gemcitabine-resistant SWl990/GZ SWl990 dosage gemcitabine intermittently months. 4983 13310 &gt; 2-fold gemcitabine-resistant, 1993 2990 4759 2-fold, 2671 2088 Ontology (RP11-58D2.1, lincRNA-ZNF532, AP000221.1, CTC-338M12.5, CR619813, DDX6P) (SYT1, FAM171B, ZNF331, FAM187B, CYP1A1, SRXN1, HIST1H2BL, TOMM40L SPP1) SW1990 SW1990/GZ. lincRNA-ZNF532 time-dependent. Gemcitabine 1.0 μM 16.0 DDX6P lincRNA-ZNF53 circumstance. candidates targets. WT1-AS cancer.Tumor obstacles successful diagnosed behavior. newly-identified WT1-AS. proportion ectopically-expressed ERK phosphorylation. triple-negative cancer.Triple-negative (TNBC) TNBC array. 1,758 1,254 (≥ change), TNBC. XR_250621.1 NONHSAT125629 employed findings, microarrays. KEGG microtubule motor light exploring transition.BACKGROUND: (SPRY4 intron SPRY4 Hence, carcinogenesis.METHODS: QRT-PCR 61 (RNAi) SPRY4-IT1. pCDNA-SPRY4-IT1 injected immunohistochemistry. ChIP Student's (two-tailed).RESULTS: depth controlling contributed (EMT) process.CONCLUSION: Specificity (Sp) metformin HULC.Specificity (Sp1) (TF) SNU-449 SK-Hep-1 Sp1 Sp3 Sp4 Sp RNAi Sp1, Sp3, context- response-dependent. differentiated morphological changes, Sp1-regulated mesenchymal inverse antidiabetic down-regulates metformin, antineoplastic agents applications detection.Prostate males. urgent unmet sensitive overtreatment accompanying morbidity. (AK024556, XLOC_007697, LOC100287482, XLOC_005327, XLOC_008559, XLOC_009911) prostatic (Gleason &gt;6.0) (healthy) urine. AK024556 (SPRY4-IT1) LNCaP, Chromogenic paving diagnostics. RNA-based distinguish precancerous lesions. Skp2 Meg3 miR-3163.Maternally (Meg3) E3 ubiquitin ligase SCF ubiquitination-associated degradation CDK Nevertheless, acknowledged. Meg3, p27 altering miR-3163 bound 3'-UTR translation, supported augmented binding-induced enhancement, double fluorescent co-localized intracellular NT, require coordination Meg3. translation preeclampsia placenta pathogenesis.BACKGROUND: preeclampsia. Preeclampsia molar pregnancy fetus absent, sufficient condition. placentas.METHODOLOGY/PRINCIPAL placentas (T) (N) varied accounting microarray, 28,443 detected. 738 1.5-fold-change) Coding-non-coding (CNC network) According CNC lncRNAs/mRNAs, LOC391533, LOC284100, CEACAMP8 controls.CONCLUSIONS/SIGNIFICANCE: clusters Misregulation Epigenetic GPR1AS Zdbf2linc.Long genomes, mice, Zdbf2linc isoform Zdbf2 undefined, parent-of-origin-specific neighbors Nespas, Kcnq1ot1 Airn GPR1AS, GPR1-ZDBF2 region. Although ZDBF2 exons, orientation GPR1 secondary, (ZDBF2 DMR), Zdbf2linc. GPR1AS/Zdbf2linc exclusively human/mouse paternal-allele-specific maternal-allele-specific (GPR1/Gpr1 DMR). paternal-allele DMR lineage. stochastic methylation-independent, placental GPR1-GPR1AS-ZDBF2 well-conserved genomes sequence conservation divergent evolution ancestor, identical structures. Linc-ITGB1 GBC-SD/M GBC-SD lines.Gallbladder rate. modalities surgery, radiotherapy, yield outcomes. linc-ITGB1, pair metastatic linc-ITGB1 lentivirus-mediated twofold β-catenin vimentin, slug, TCF8. epithelial-to-mesenchymal transition, cases. laryngeal significance: LSCC.Long resolve larynx significance. Distinctly AC026166.2-001 RP11-169D4.1-001 87 estimated log-rank test. check value. 684 747 (fold-change &gt;2.0). distinctly dysregulated, exhibiting verified nodes (P = 0.007). 0.65 0.67, point ΔCt 11.23 10.53, Potential Contributing Pathogenesis Intervertebral Disc Degeneration Based Data.BACKGROUND: intended intervertebral disc degeneration (IDD).MATERIAL GSE56081 downloaded Omnibus database, nucleus pulposus degenerative GPL15314 platform. groups. ontology (GO) Simultaneously, weighted coexpression WGCNA package, modules. protein-protein (PPI) visualized.RESULTS: 135 170 2133 1098 UBA52 (ubiquitin A-52 residue ribosomal fusion product PPI network, Eight - LINC00917, CTD-2246P4.1, CTC-523E23.5, RP4-639J15.1, RP11-363G2.4, AC005082.12, MIR132, RP11-38F22.1 modules green-yellow module IDD. Key SPHK1, cells.Data massive cloning methods question, lncRNAs-Loc554202 control, migration/invasion impeded IFNG-AS1 Promotes Helper Cells Response Hashimoto's Thyroiditis.The (lnc) RNA-Ifng-AS1 Th1 IFNG-AS1, cells' thyroiditis (HT) Twenty-eight HT enrolled T-bet, IFNG anti-thyroglobulin antibody/thyroperoxidase antibody translational CD4(+) T-bet lncRNA-IFNG-AS1 HT. LINC00312, carcinoma.The NAG7, cloned LINC00312 stimulate aims 561 cores, epithelium Positive 0.001) 0.001, sensitivity: 72.1 %, specificity: 87.7 %). EBER-1, Epstein-Barr Virus, (r -0.384, final logistic EBER-1 contributors (Disease Free (DFS): 0.005, Overall (OS): (DFS: 0.011, OS: 0.017). osteoarthritis humans.OBJECTIVE: (OA) OA versus cartilage.METHODS: cartilage, cartilage OA, (MMP)-9, MMP-13, (BMP)-2, COL2A1 ADAMTS5, cartilage.RESULTS: 121 73 48 cartilage. Twenty-one twofold. HOTAIR, PMS2L2, RP11-445H22.4, CTD-2574D22.4, MMP-9, BMP-2, ADAMTS5 cartilage.CONCLUSION: OA. miR-140.The obstacle preventing quantities drugs. (MALAT1) microvessels (GECs) co-culturing impairment occludin miR-140, miR-140 exerted. YA (NFYA), CCAAT box-binding factor, function. NFYA up-regulate fact BTB, establishing strategies gliomas. pluripotency differentiation.The (ES) lineage specification considerable attention. (ncRNAs), appear developmentally untested. ES custom-designed embryoid bodies (EBs) 16-d course. 945 EB 174 expressed, correlating events. Candidate examination profiles, context, state, coordinated genomically Dlx1, Dlx4, Gata6, Ecsit. Evx1as Hoxb5/6as, homeotic share localization embryos trimethylated H3K4 histones MLL1, directing alternative programs, engagement machinery. CCAT2 prognosis.INTRODUCTION: cancer.METHODS: 85 value, method, distance progression, lncRNA-UCA1 plasma.OBJECTIVE: nontumourous agarose gel electrophoretogram Clinicopathological associate measurements 60 0.881). 0.886; efficacy patients.AIM: PVT1) paper PDAC.METHODS: N-classification PDAC.CONCLUSION: Predictive polymer modeling coupled fluctuations conformation transcription.A organization, topologically domains (TADs), uncovered capture (3C) techniques. TAD structure conformations TADs population-based 3C actual physical distances extent chromosomal contacts vary boundaries genetically elements TADs. Combining model's predictions high-resolution FISH X-inactivation center (Xic), spatial proximity elements. occur context fluctuating loops asymmetric Xic inactivation. CRNDE, long-noncoding signaling.The Neoplasia Expressed recognized brain, gliomas manifests acetylation Target Rapamycin (mTOR) utilizing MINCR MYC-induced MYC's Burkitt lymphoma cells.Despite MYC impact regulators, transcriptome. intersected MYC-inducible 91 B-cell lymphomas overexpression. IG-MYC-positive direction (MINCR), MYC-positive lymphomas. Differential modulator program. Aurora kinases licensing We, therefore, player GAS6-AS1 NSCLC.Lung China world. oncogenesis. (GAS6 0.032) 0.003). 0.036). GAS6 (growth-arrest-specific gene6) (Pearson's -0.620). promised DNMT1-associated epigenome instability 3300 (lnc)RNAs chromatin-modifying complexes. methyltransferases RIP-seq, line, TCONS_00023265, DACOR1 (DNMT1-associated Repressed high, crypts) panel patient-derived occupancy DACOR1, (DMRs) Induction colonies Cystathionine β-synthase, S-adenosyl methionine-the methyl donor methylation. understood.METHODS: HNF1A (HNF1A-AS1) 161 GC.RESULTS: 2.06, p &lt; 0.05), (AGS, MKN-45) (GES-1), non-neoplastic (low 161; rate, 58.38%). size/diameter (p = 0.005, analysis), (CEA), 19-9 (CA19-9), RRM1 (p = 0.028, p = 0.009, p = 0.006, respectively).CONCLUSIONS: GC, thus, protected exosomes non-protein-coding 152 (LINC00152) LINC00152 existence blood. sequencing. preoperative exosomes, electron microscopy. 48.1 85.2%, ones. exosomes. All possibility blood-based Use Three Non-Coding Indicators Astrocytoma.Long astrocytomas three-step astrocytoma: a) (normal tissues) microarray; b) top-hits (WHO II-IV) (qRT-PCR); c) hits astrocytomas. astrocytoma 7-lncRNA differentiate ENST00000545440 NR_002809 astrocytoma. BC002811 XLOC_010967, factors. post-surgical Gm15055 Hoxa cluster.The Hox encode silenced vertebrates. ESCs. knockout RNAGm15055 mESCs maintained OCT4.Gm15055 H3K27me3 promoters. close mESCs, facilitate Gm15055RNA OCT4-responsive locus, implies elaborate mESCs. signature Accumulated investigated.METHODS: array-based repurposing omnibus dataset datasets. eight-lncRNA signature, classified high- low-risk (median 1.67 6.06 4.33E-09). non-overlapping cohorts, demonstrating reproducibility robustness stratified tumorigenesis.CONCLUSIONS: Linc00152 Act Biomarkers Predicting Diagnosis Carcinoma.BACKGROUND/AIMS: chosen arranged sets. Additional double-blind testing suspected HCC.RESULTS: set. Areas 0.78 0.85, Combination possessed moderate 0.87 0.89 achieve fine diagnosing ontogenesis Stably Valid Endogenous Profiling Glioma.BACKGROUND: translation. Thereby, tumourigenesis. Thereby valid requires suitable, stably normalisers reliable reproducible suitable references yet.METHODS: specimen (WHO-Grade II), anaplastic III) IV) matter. procedure rigorous bioinformatical selection inclusion abundant, equally NormFinder algorithm.RESULTS: appropriate astrocytoma, 22 Comparing Addition lncRNAs.CONCLUSIONS: (HOXA6as, Zfhx2as BC200) universal applicable accurate normalisation (WHO-Grades enables perform longitudinal e.g. malignisation driving transformation. [Expression radiotherapy-resistance radiosensitivity].OBJECTIVE: lines.METHODS: Colony HT29, SW480, RKO, Lovo irradiation Radiation (SF2 value). High-throughput chip RKO Lovo. realtime low) HT29 (0.83 ± 0.03), SW480 (0.69 0.02), RKO(0.53 (0.47 (0.32 0.03) 0.01). screened. R05532, NR_015441, NR_033374 resistance(all NR_073156 AA745020, (both P&gt;0.05).CONCLUSIONS: NR_015441 lncRNA-HMlincRNA717 significances.Long gradually tumor-associated years. HMlincRNA717 313 centers, levels, AGS, HGC-27, MGC-803, SGC-7901, 62.6 (67/107) (P = 0.034), venous (P = 0.029), (P = 0.024). Involvement (linc-VLDLR) chemotherapy.Hepatocellular treatment-refractory adverse stress. behavior (EV), end, EVs cell-derived lincRNA-VLDLR hepatocytes. Exposure anticancer sorafenib, camptothecin, linc-VLDLR viability abrogated VLDLR ABCG2 2), sorafenib-induced death. EV-enriched responses.IMPLICATIONS: cancer.Gastric serious threat health 3141 Linc00261, DKFZP434K028, RPL34-AS1, Linc00152. decline DKFZP434K028 trigger program, delineate lncRNA-based cancer.This (EC) technique pieces pathologically-proven frozen liquid nitrogen stored -80°C use. analyses) performed. EC, consistency 30586 26109 (fold ≥ 2.0) EC. 4010 3350 down-regulated. Seven transcripts, beneficial chondrogenic completely view studying undifferentiated 3638 &gt;2.0 &lt;-2.0, consisting 2166 1472 ZBED3-AS1 CTA-941F9.9 complicated However (BANCR) eighty-four depth, HOTTIP migration.HOTTIP HOXA WD repeat (WDR5)/mixed (MLL1) (siHOTTIP) Panc1 siHOTTIP, 757 514 complex. example, A, coregulated MLL WDR5 HOXA13 HOXA10, HOXB2, HOXA11, HOXA9 HOXA1. HOX-associated pro-oncogenic strikingly Macrophage infiltration UCA1.There macrophage playing profiling, conditioned (CM) macrophages. CM (UCA1). AKT CM. results; UCA1. HOXA11-AS, ovarian (HOXA) female reproductive embryogenesis 5-prime (HOXA10-AS, HOTTIP) underexplored (EOC). EOC 1,201 serous 2,009 exonic rs17427875 (A&gt;T), marginally (OR 0.88 0.78-1.01, 0.06). HOXA11-AS minor allele A. allele. modified germline LOC285194 hot topics attracted LOC285194, osteosarcoma. survival.METHODS: 81 follow-up mucous CRC, outcome.RESULTS: (p&lt;0.001) (p=0.015), (p=0.034), (p=0.046). free (p=0.010). disease-specific survival.CONCLUSION: implicates AC068718.1, post-traumatic women.Posttraumatic (PTSD) debilitating mental burden PTSD heritable women correlational connections sex-linked vulnerability, extend disorder's architecture. (GWAS) American sample Detroit Neighborhood Health (DNHS) European Nurses II (NHSII). genotyped 413 DNHS 319 exposed traumatic event Illumina HumanOmniExpress BeadChip &gt;700,000 578 1963 NHSII replication. network-based GWAS-derived Reactome database NHSII. top GWAS telomere maintenance shaping phenotypic differences. Downregulated Downregualtion Expression.BRAF pCDNA-BANCR-mediated p21, posttranscriptional. Genetic paranoid schizophrenia Chinese Han population.The heritability ~80%, estimated. (LncRNAs) pathophysiology schizophrenia. tag cover (discovery Shanxi Province: 1093 1180 subjects; Jilin 1255 1209 controls). discovery rs1894720 (χ(2)=74.20, P=7.1E-18), 1.70 CI=1.50-1.91). (χ(2)=22.66, P=1.9E-06, OR=1.32, 95%CI 1.18-1.49). genotypic rs4274 (χ(2)=4.96, df=2, P=0.03); AA (OR=1.30, 95%CI=1.03-1.64). haplotype Considering locate regions, regions. ceRNA Nanog sponging miR-145 cancer.lncRNAs typical (PCSCs) PCSCs Insights (ceRNAs) gained ROR/Nanog Compared tumourigenicity ceRNA, effectively sink miR-145, derepression Nanog. conclusions, surgery rational LUADT1, p27.Long (LUAD). microarrays LUAD non-smokes LUAD. 498 1691 (LUADT1), LUADT1 G0-G1 SUZ12, metastasis-associated pre-operative HCC, progressively significant. infection, cirrhosis. receiver-operator 1.60 0.66. vitamin K II, α-fetoprotein, 88.6% 75%, lymphocytic leukemia.Mutations dismal (CLL). Whereas assessment CLL missing. exploited map describe microRNA/non-coding CLL. Besides miR-34a, (miRNAs; miR-7-5p miR-320c/d). miRNAs, (lincRNA-p21) lincRNA-p21 isogenic dependence lincRNA-p21. miRNome machinery lymphoma. adenocarcinoma.Long HNF1A-antisense 2455-bp UCSC Genomics Browser's plot experienced E-cadherin, N-cadherin HOTAIRM1, leukemia, intermediate-risk cytogenetic category, distinctive signature.Long unknown.We (HOTAIRM1) 241 HOTAIRM1 profile. 215 (IR-AML) patients.The lowest promyelocytic t(6;9) 0.005). IR-AML (OR:2.04;P leukemia-free (OR:2.56; (OR:1.67; 0.046). favorable (OR: 3.43; 0.009). NPM1-mutated retained 2.21; 33-microRNA miR-196b classify high-, intermediate-, (5-year 24% 42% 70%; 0.004).Determination refinement strengthened 33-miRNA signature. adenocarcinoma.INTRODUCTION: (PDAC).METHODS: duct lymphnode NUF2 AF339813.Recent (Ndc80 kinetochore component) stronger Apoptosis cytometry. MTT. CDK4/CDK6 AF339813, NUF2, siRNA. Through AF339813 NUF2. meditator AF339813. Tumor MT1DP YAP Runx2 FoxA1 cells.Recent indicative carcinogenetic Runt (Runx2) Yes (YAP) illusive. vice versa. Rux2 Metallothionein 1D, Pseudogene (MT1DP) binding. soft agar, effect, suppressor. Alfa-fetoprotein (AFP), classic synthesis Forkhead box (FoxA1), Specially, opening compacted CREB site CREB-mediated MT1DP-inhibited FoxA1, YAP. Rnux2 pro-carcinogenetic lipid miR-9-mediated RXRA pathway.HULC setting hypothesis acyl-CoA synthetase subunit ACSL1. Immunohistochemical 77% (180/233) ACSL1 PPARA, miR-9 PPARA eliciting lipogenesis, triglycerides Strikingly, generates upregulate retinoid RXRA, deregulating miR-9, reinforced feed-forward drive NBAT-1 carcinoma.OBJECTIVE: accumulating (NBAT-1) initially (ccRCC). ccRCC.METHODS: 786-O ACHN cells.RESULT: tubule HK-2, invasion.CONCLUSIONS: progression; AK022798 expression.Gastric failure. drug-resistant First, SGC7901/DDP BGC823/DDP vector plasmid; transfection, 1. multidrug resistance-associated (MRP1), P-glycoprotein, reduced. interfere MRP1 P-glycoprotein (NPC). domain.METHODS: GSE12452 reannotated quantify NPC.RESULTS: NPC, lnc-C22orf32-1, lnc-AL355149.1-1, lnc-ZNF674-1 lnc-C22orf32-1 male stages. Recurrent lnc-BCL2L11-3 tissues.CONCLUSIONS: feasible reannotation. gender recurrence. cancer.Breast globally. morbidity mortality, tendency metastasize organs, warrant urgency (shRNA) depletion. Breast abilities Cdc25C interrupting osteosarcoma.The osteosarcoma (TUG1) Seventy-six 29 pre-operation post-operation, 42 diagnosed, relapse, post-treatment, 36 tumor, reactions (P &lt; 0.01) post-operative chemotherapy, Enneking surgical (HR = 2.78, CI = 1.29-6.00, P = 0.009) (HR = 1.81, CI = 1.01-3.54, P = 0.037). nomogram (c-index 0.807 0.776, ΔCT -4.98 ± 0.22) -6.09 ± 0.74), status. (ALP) 0.849 0.544). surveillance forecasting LINC00982 cancer.Emerging evidences LINC00982, 106 (P = 0.004), (P = 0.005). [area (AUC) = 0.742; 95 % (CI) = 0.678-0.800, P &lt; 0.01]. marker. (P = 0.026). rendered P16 Hotair pathways.Nasopharyngeal (NPC), head neck prevalent geographic areas eastern Asia. options unsatisfactory radio-chemotherapies. urgently needed therapies extremely VEGFA GRP78-mediated Ang2 XLOC_010588 c-Myc cancer.OBJECTIVE: progression.METHODS: 218 XLOC_010588. BrdU proliferation.RESULTS: SCC-Ag. Ectopic HeLa SiHa HCC94 physically c-Myc, tissues.CONCLUSION: has-miR-526b binding-site rs8506G&gt;a polymorphism lincRNA-NR_024015 GWASs predispose non-cardia risk.Gastric cardia Asian (GWASs). populations. risk-related 438 727 populations regression. rs8506AA carrier (adjusted [OR] = 1.56, 95%CI = 1.03-2.39, rs8506 AG GG genotype. pronounced smokers (P = 0.001). Biochemical rs8506G&gt;A disrupts has-miR-526b, rs12325489C&gt;T lincRNA-ENST00000515084 GWAS-based analyses.Breast malignancies polygenic role. Thus far, woman long, intergenic, 16 2539 2818 eastern, southern, C [OR] = 1.79; [CI] = 1.50-2.12), rs12325489TT miRNA-370, modifier Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant Cancer.Estrogen (ER)α-positive ERα antagonists synthesis, resistance, underlie estrogen-activated single-molecule estradiol-induced luminal A-type MCF7 T47D. libraries prepared polyadenylated hours vehicle Single-molecule technical replicates performed, series, 1000 Non-protein Coding 1016 (LINC01016) LINC00160 ERα, relation consequences. endocrine explore. Combined c-ABL HOTAIR.Triple-negative designated FDA-approved (EGFR) TNBC, underwhelming. co-treatment (imatinib) (lapatinib) synergistic dual (HOX RNA). Depleting phenocopies suppression. LEF1/TCF4-binding site. blocks prevents forced elucidates linking gain. HOXD-AS1 HOXD transcriptome.BACKGROUND: major, Significant platforms, ignored studies.RESULTS: pipeline annotate popular U133 microarrays, creating resource 1581 fall Remarkably, 159 discriminates differentiates relapsing non-relapsing example solely. HOXD-AS1, evolutionary hominids bona fide Studying SH-SY5Y morphogenic PI3K/Akt RA-induced Knock-down inflammation, hallmarks cancer.CONCLUSIONS: functionally neuroblastomas. cumulus PCOS patients.PURPOSE: polycystic ovary syndrome (PCOS) employing in-depth PCOS.METHODS: (five women). enhancer-like lincRNA) deduce lncRNA/mRNA Cytoscape software (V2.8.3, http://www.cytoscape.org/ ).RESULTS: 623 260 (mRNAs) discriminate (XLOC_011402, ENST00000454271, ENST00000433673, ENST00000450294, ENST00000432431) enhancers Forty-three construct coding-non-coding correlated, women, oocyte regulation; Acute rare children; Arraystar 372 (difference ≥10-fold) Fifty-one upregulated, &gt;10-fold AML, terms pathway-related 97 ENST00000435695 ENST00000415964 Data immunoresponse. bbdiagnostic New Pair Cumulus Correlate Oocyte Maturation Embryo Development.The noninvasive aid embryo fertilization outcome. maturation, fertilization, valuable AK124742 PSMD6, PSMD6 oocytes high-quality (HCCs) poor-quality (PCCs) transcriptase receiver-operating curve. HCCs PCCs (72.5% 62.5%, respectively; .01). nonpregnancy .01).The interval: 0.64-0.93). lncRNA-messenger selection. Effects oestrogen alpha-positive cells.Although (E2) (EOC) E2 hormonal 115 ≥1.5, P&lt;0.05) (ER) alpha (ERα)-positive SKOV3 E2-untreated ERα-mediated; candidates. TC0101441 TC0101686 ERα-positive PEO1 ERα-negative A2780 ER ICI 182, 780 (ERα-shRNA). Particularly, potential. pro-metastatic E2-induced partly, MMP2 MMP3. demonstrate, ERα-mediated. TC0101441contributes migration/invasion. estrogenic perspective Fer-1-like miR-106a-5p cancer.Novel (FER1L4) (ceRNA) FER1L4 lower, miR-106a-5p. Restoration miR-106a-5p, striking increased, surgery. least, FER1L4, prevention ZNRD1-AS1 HBV development.Zinc ribbon (ZNRD1), leukocyte (HLA) integral (ZNRD1 ZNRD1. 1300 1344 persistent clearance associations ZNRD1 (rs3757328, rs6940552 rs9261204) Logistic additive alleles risk, rs3757328 clearance. OR = 1.18, CI = 1.01-1.38, P = 0.035) OR = 0.83, CI = 0.71-0.96, P = 0.013), haplotype. HepG2.2.15 makers cancer.Lung Early importance. Initially, consecutive deplete NCI-H446 HOTTIP, Cdc25C, HOTTIP. Pro-apoptotic Bad anti-apoptotic Bcl-2 Bcl-xL ablation. code 30,586 26,109 probes. 27,279 2,331 (P&lt;0.05; T/N&gt;2.0) 1,641 N/T&gt;2.0) 19,995 1,676 1,981 N/T&gt;2.0). 41 (P-value consistent. differed revelation noteworthy. potentials outstanding mortality. discover lncRNA-associated clarified.METHODS: node-metastasis Twelve XLOC_010235 RP11-789C1.1 (tumour, metastasis) different. Via high-expressed low-expressed inverse-expressed RP11-789C1.1.CONCLUSION: posits pathway.In carcinoma, cancer; paper, (RT-qPCR) Natural eye development.Natural (NATs) relevant. (Pax6, Pax2, Six3, Six6, Otx2, Crx, Rax Vax2) mature processed unprocessed undergo splicing. NATs, counterparts, display predominant retina, postnatal Vax2OS (Vax2 strand) carrying Vax2, NAT, CrxOS, retina adeno-associated Crx. counterparts conditions. ZEB1-AS1 survival.BACKGROUND: LNCRNA (QRT-PCR) determined.RESULTS: ESCC.CONCLUSION: HIF 1α-anti-sense transforming factor-β-mediated sirtuin osteoblastic stromal 1α-anti‑sense HIF1α-AS1) osteoblast (SIRT1), (TGF)‑β (BMSCs). Real‑time (PCR), arrays SIRT1 TGF‑β, HIF1α‑AS1 (HOX)D10, BMSC HIF1α‑AS1. TGF‑β interfered SIRT1. block HOXD10. HOXD10 acetylation, mediator gene‑therapeutic micropeptide performance.Functional micropeptides concealed noncoding. micropeptide, myoregulin (MLN), muscle-specific MLN shares similarity phospholamban (PLN) sarcolipin (SLN), SERCA, pump relaxation Ca(2+) uptake sarcoplasmic reticulum (SR). SERCA impedes SR. PLN SLN, slow robustly muscle. handling exercise performance. physiology circuitry differentiation.Although mammals, characterized, debate this, consequences patterns, comparable well-known regulators. trans. dozens commitment programs. integrate state. carcinogenesis.Gastric ranks digestive China. Few reports 1,297 2,037 clustered lincRNA-BBOX1-2, CR594506 BC015134 twenty-six clues pathways.Lung (LC) mortal lethal life. LncRNAs, understood, LC. LC When tranfection pcDNA-BANCR vector, suppressed. Vise versa, si-BANCR, promoted. BANCR-mediated MAPK, p38 inactivations. future, TSIX scleroderma dermal collagen stabilization.Long silencing. sclerosis (SSc) hybridization. analysed immunoblotting TSIX, SSc (TGF)-β1 I fibroblasts, cytokines. stability, half-lives. SSc, stabilizes TGF-β constitutive skin siRNAs. Specific Show Patterns Competing Carcinoma.Long NCBI GEO (GSE65485) (or lncRNAs) miRcode, starBase, miRTarBase, lncRNA-miRNA-mRNA (ceRNA 177 1.5, discriminatively race, AJCC Six (CECR7, LINC00346, MAPKAPK5-AS1, LOC338651, FLJ90757, LOC283663) (OS, 14 17 perturbs circadian rhythm hepatocarcinogenesis.Clock (CLOCK)/brain arnt-like protein-1 (BMAL1) triggering periodic clock (HULC), perturbations heighten CLOCK oscillators, period cryptochrome 1, prolonged pairing untranslated underlay HULC-modulated CLOCK, mutants failed event. staining experiments, HULC-accelerated HULC, responsible oscillator promotion accelerates hepatocarcinogenesis disturbing risk-associated differentiation.Neuroblastoma embryonal sympathetic extracranial childhood. transcriptomes low- neuroblastomas, nonannotated 6p22 Loss neuronal-specific NRSF/REST. impairing precursors. p16(INK4A) senescence.Oncogene-induced (OIS) insults tumour OIS p16(INK4A)-dependent Under cytoplasm, B-RAF cytoplasm. INK4A (PcG) proteins, PcG-mediated INK4A, lncRNA-mediated p16(INK4A). alpha-regulated androgen (AR) cascade Some escape (ERα) AR ERα-specific putatively ERα-regulated recalcitrant antagonists. favour carcinoma.Recently, Hepatitis HCV-related preneoplastic lesions LINC01419 AK021443 AF070632 HBV-related cofactor oxidation-reduction carboxylic catabolic large-scale survey LncRNA-AP001631.9 cancer.Recently, multigenetic (LncRNA-AP001631.9), FOXM1, FOXM1. migratory MGC803 movement tail injection administered, LncRNA-AP001631.9. IGF1R malignancies.Dysregulation insulin-like (IGF1R) abundantly kinases, IRAIN, IRAIN paternal counterpart silenced. transcription-associated trap intrachromosomal enhancer/promoter loop. abolishes interaction. microarray.BACKGROUND: (RCCC) nontumorous microarray.METHODOLOGY/PRINCIPAL 17157. fold-change) RCCC 916 RCCC. ENST00000456816, X91348, BC029135, NR_024418 sixty-three histologically tissues.CONCLUSIONS/SIGNIFICANCE: myometrium sense-antisense spontaneous labor term.OBJECTIVE: term.MATERIALS Myometrium cesarean deliveries (n 19) term 20). Illumina® representation platform, co-differentially sharing loci.RESULTS: co-differential coding-lncRNA pairs: SOCS2-AK054607 LMCD1-NR_024065 term. element, site, lacked primates.CONCLUSIONS: provide, cis-encoded SNHG15 GC.Accumulation SNHG15, (P = 0.001), (P = 0.019). (area (AUC) = 0.722; (CI) = 0.657-0.782, P &lt; 0.01). MMP9 STAT3‑regulated lnc‑7SK lnc‑IGF2‑AS replication.Long high‑throughput sequencing, infections intensively examining HCV transducer activator (STAT3) (HCV) HCV. detailed arrays, lnc‑IGF2‑AS, lnc‑7SK, lnc‑SChLAP1 lnc‑SRA1 STAT3. Huh7 phosphatidylinositol 4‑phosphate (PI4P), replication, STAT3 PI4P. CASC2 miR-21.Long (cancer 2) lowly U251 U87 MicroRNA-21 (miR-21) miR-21 Argonaute2-dependent bioinformatics, sequence-specific Introduction CASC2-mediated miR-21, Nexus: phenotype-specific revolutionary tool research. features: archives coding-transcript networks; phenotype-oriented organization searching (iii) visualization networks. meets Nexus (CRN, http://syslab4.nchu.edu.tw/CRN). CRN user-friendly web interface personalized medicine. intuitive exploration, coding-transcript/lncRNA generating hypotheses LSAMP TUSC7 microdeletion/duplication 3.The 3q13.31 delay, mean, facial features, genitalia. osteosarcomas. limbic system-associated (LSAMP), (TUSC7), suggested. case rearrangement extra 3q13.31-q29 translocated arm Y chromosome. karyotypic aberration dysregulation. overexpression, position bearing cryptic deletion. WT1 (AWT1) Wilms' tumours.The WT1, 10-15% tumours zinc-finger nephrogenesis, genitourinary haematopoiesis sex determination. AWT1, co-expressed haematopoietic AWT1 10, deploys 5'-exon WT1. 33 kDa, kidney, monoallelic (WT1-AS) kidney confined biallelic WTs. 11p13 bias variable penetrance syndromes inherited mutations. Systematic cervix threatens separately, online databases. quantity techniques, 1622 3026 (fold-change&gt;2.0) afforded key-lncRNAs Evolutionary 11 transcripts.We processed, interest, limbs (Hsieh-Li al. 1995). cDNAs sequenced, mouse, 3' strand frame observed, mouse-human argued true Murine examined, revealing limb kidney. procedure, Race Circles, devised start sites. chicken respective homeodomains pressure vertebrates changes. Given amino observation argues homeodomain specificity. facilitated tracking function.In epsilon-globin HS2 Locus Control Region away. established. (pol II) TBP tracks DNA, synthesizing short, polyadenylated, Guided delivers pol cis-linked globin insulator inserted traps blocking mid-stream complex, 7SK induction.7SK (snRNA) 331-333-bp HEXIM 1/2 elongation (P-TEFb) P-TEFb alleviating promoter-proximal paused (Pol initiating productive Without Pol hypophosphorylated occurs. over-expressing snRNA (HEK) 293T viability, inhibition. anti-cancer agent, RNA's Evaluation han chinese myopia.High myopia blindness unraveled attempts elucidation. (SNPs), rs2969180, rs1652333, rs9307551, rs7837791, Caucasians. Chinese. SNaPshot composed 827 988 genotyped, rs9307551 Carriers rs9307551A AA, AC genotypes 1.33, 1.14-1.54; 1.75, 1.28-2.38; 1.59, 1.24-2.01, resp.). split gender-specific females LOC100506035, myopia. Reversibility fibrosis: Implications therapy.Liver continues problem worldwide If eliminated, progresses cirrhosis malignancy; fatal transplantation, curative therapy, unavailable. process; complete reversibility debatable. transmitted generations. posttranslational determinants fibrogenesis mitosis meiosis daughter resolution inheritance communication delineating multigenerational transgenerational mutations, pharmacologically underscores opportunity fibrosis, thromboembolic hypertension.Chronic hypertension (CTEPH) hypertension. CTEPH, arteries CTEPH 185 464 enhancer‑like overlapping, pairs. Coexpression NR_036693, NR_027783, NR_033766 NR_001284, stimulus presentation. planning, CTEPH. management Alternative Nesp Gnas Chr Nesp--Gnasxl--Gnas maternal-specific Gnasxl biallelically lies Nesp, expresses unspliced Large clusters, Nepas, alternatively spliced Nespas 1.4 non-coding. expressed; 2.5 ATG Nesp. correspond region; counterpart, patterns. important. Single monocytes.We allele-specific 188 Monocytes purified variation 8929 harboring retrieved ENCODE 60% Focusing 258 489 informative bivalent, poised modifications. Out SNPs, 20% (n = 52) co-regulated closest catalog 32 p-values 6.7×10(-7) 9.5×10(-89). system, arthritis. remodeling complexes RNA-dependent bodies.Paraspeckles subnuclear assemble paraspeckle (lnc)RNA. Paraspeckle biogenesis prion-like (PLD) RNA-binding SWI/SNF components (PSPs) NEAT1. ATP-dependent Instead, PSP assembly. collectively PSPs recruit Sat III (Satellite lncRNA-dependent Organization omega speckle Drosophila depends raise body Repressing repressor: self-renewal.Large (linc) dimension In this issue Developmental Cell, Wang et al. (2013) self-renewal Oct4, Nanog, Sox2. lncRNA-disease constructing miRNA.Accumulating dysregulations Developing disease-lncRNA benefit prevention. HyperGeometric LncRNA-Disease inference (HGLDA) miRNA-disease lncRNA-miRNA HGLDA rely associations, 0.7621 leave-one-out cross validation. Similarity Calculation MiRNA (LFSCM) calculate scale semantic similarity, miRNA-lncRNA anticipated LFSCM biomedical enhancer-associated disease.The units enhancers. Enhancer approach, generate morphogenesis. emergence states, Orthologous hearts progenitor cardiomyocytes sequences. multi-exonic reactivation hallmark heart, enhancer-derived psoriasis sample: mechanisms.To psoriasis, high-throughput lesional psoriatic skin. RNA-derived DNAs 92 82 punch biopsies, ∼38 single-end 80-bp Comparison Weighted (WGCNA) coordinately TINCR, staufen-1 (STAU1), p63 ZNF750, KLF4. Other IL-17 keratinocytes. Dermally expansion compartment. circuits emphasize architecture FOXG1 ring 14.In 14, intellectual disability, epilepsy, paresis, tetraplegia, osteoporosis thoraco-lumbal scoliosis. CGH imbalance karyotyping interstitial 14q12q24.3 material. breakpoints base-pair mate-pair Sanger (TCONS00022561;RP11-148E17.1) breakpoint 225 kb forkhead (FOXG1), FOXG1. r(14) arising compatible turn, case, classical r(14)-syndrome, mosaicism. adrenocortical recurrence.Adrenocortical (ACC) resection. adrenal characterised signatures, extends ACC, adenoma (ACA) (NAC) ACC freshly histopathology. Focused ArrayStar transcriptase-PCR (ten ACCs, ACAs NACs) 956 NAC, carcinogenesis-related PRINS (P≤0.05); ACA (P≤0.05). Hierarchical correctly NAC ACA. Sixty-six (P≤0.05), PRINS, ACCs Unbiased Capture Hi-C.Genome-wide 70 risk. deserts, kilobases lacking deserts harbor Hi-C (CHi-C), incorporating protocol, CHi-C 2q35, 8q24.21, 9q31.2. peaks ("bait fragments") captured "targets" 6.6 2.6 Mb. IGFBP5, KLF4, NSMCE2, MYC; DIRC3, CCDC26. desert, (rs12613955 rs4442975) mapped bait peak. ChIP-qPCR rs4442975, FOXA1 variant. estrogen-regulated HER2 cancer.Among ER-positive independence, 800 estrogen-dependent estrogen-independent derivative MCF7:2A (MCF7:2A) NanoString. let-7c, miR99a, miR125b, LINC00478. (TCGA). uniformly lost miR125b let-7c TCGA. ER-regulated HER2, ER(+) transcriptome.Using (RNA sequencing) ribosome-depleted 1,273 (long RNAs) P493-6 B-cells. 534 TSS (transcription sites) MYC-responsive concordance determinant additional, differentiation-specific MYC-bound polyadenylation. NRO (nuclear run-on) (quantitative PCR). balanced t(2;6)(p15;p22.3) West Syndrome lnc-RNA.In perfectly balanced, 46,XY,t(2;6)(p15;p22.3). positional excluded BX118339, spans 6. patient. 7SL virus-like particles S-domain fragment.HIV-1 package virions yielded conflicting minimal, assembly-competent (VLPs). VLPs retain endoribonucleolytic fragment, referred remnant (7SLrem). Nuclease 7SLrem 111-nucleotide internal portion 7SL, unpaired two-dimensional structure. comprised Gag NC-positive domain. Because 7SLrem, domain, assembling endoribonuclease NC. VLPs, 7SL's indirectly, C-terminal CA. Transposable origin, diversification, vertebrate RNAs.Advances genomics progress elucidating origins evolution. transposable (TEs) makeup zebrafish. Surprisingly, TEs thirds substantial (~30% human), expected, TE families interspecific coverage embedded reflecting surveyed. evolve constraint non-TE sequences, TEs, random DNA. constraint, ~30,000 initiation, polyadenylation human. ~35,000 density marks cis-regulation. recapitulated Finally editing ubiquitous lineage-specific diversification repertoires. modulations Parkinson's leukocytes sequencing.The continuously lifespan incidence, calling inexpensive Analyzing commonplace. junctions events precisely sensitively platforms. workflow whole-transcriptome updated version AltAnalyze, high-confidence events, protein-domains annotations. (PD) pre- post- Brain Stimulation (DBS) Disease-mediated usage N-termini, 5'-end mutually-exclusive exons. PD FUS HNRNP PD-induced 6,000 post-DBS. U1 spliceosomal RP11-462G22.1, entailing complementarity microRNAs. unaffected brains 7,000 brain-expressed 3,495 U1, increases. validations co-increases amygdala substantia-nigra, multi-level inspection Wnt/β-catenin pathway.The cancers; concerning retinoblastoma. retinoblastoma, quantified 63 work. pcDNA3.1-MEG3 si-MEG3, assayed. TOP-Flash IIRC 5-aza-CdR influences short-lived surrogate chemical response.Abiotic biotic stressors sudden environmental homeostatic, ecological, networks, stresses. (MIR22HG, GABPB-AS1, IDI2-AS1, FLJ33630) (cisplatin, cycloheximide, mercury (II) oxide) Tet-off general stressors. decay interruption responses. spinocerebellar neurodegeneration staufen Drosophila.Spinocerebellar Ataxia (SCA8) appears triplet expansion-induced Little SCA8 neurodegeneration. operates, Drosophila. late-onset, progressive retina. sensitized background screen, genes: staufen, muscle-blind, ends, CG3249. neuronally wild-type repeat-expanded neurodegeneration, strength backgrounds, CUG expansions demonstration Staufen undergoes SCA8-based screens designing interventions treat Genome-scale (SQCC) scale. SQCC Trizol reagent. 47 R Bioconductor. 2,748 852 category Subgroup 46 smoking moderately subject. SQCC. retinopathy Japanese population: RNA.Elucidation (DR) DR, three-stage DR 837 (cases) 1,149 (controls). scan 446 (205 controls) 614,216 249 (335 288 297 620 rs9362054 RP1-90L14.1 borderline (Pmet = 1.4×10(-7), meta-analysis model). (lincRNA) KIAA1009/QN1/CEP162 gene; CEP162 ciliary zone ciliogenesis. raises ciliary-associated DR. Do (LincRNA-p21, GAS HOTAIR) chemoradiotherapy?Long (HNC). (lincRNA-p21, HNC radical (CRT). Forty-one (n = 27, 65.9 %) Blood drawn baseline 4.5 months semiquantitative RECIST PERCIST criteria magnetic resonance imaging (MRI), positron emission tomography computed (PET/CT) findings. Complete (CR) 73.2, 36.6, 50 % investigation, PET/CT-, MRI-based evaluation, CR (PR)/progressive (PD). post-treatment PR/PD (p = 0.01). operator 77 %, pretreatment (p = 0.042). factors.Long neurogenesis. out. (hESCs) paradigm hESCs efficiently neurons, hESC-specific identified, SOX2, component, SUZ12. neurogenesis, REST indispensable evolution, plasticity disease.Novel pace, driven shifts architecture, output, innovations systems molecules; engage structural, activities; transcriptional, expanding inventory spectrum synaptic analysis.Glioma, high-grade throughput 1,111 639 472 ≥2.0). (Gene ontology) connected recurrence, AC016745.3, XLOC_001711, RP11-128A17.1. researches SNP@lincTFBS: sites.Large (TFBSs) candidates, SNP@lincTFBS, devoted TFBSs 6,665 6,614 2,423 ChIPSeq dataset, 139,576 304,517 4,813 Project SNP@lincTFBS disease-associated flexible searches downloads. Quick query name, identifier, name. convenience interpret discrepant http://bioinfo.hrbmu.edu.cn/SNP_lincTFBS. Roles immunodeficiency replication.MicroRNAs review, (HIV) discussed. review replication-proteins steps 'tip iceberg'. discusses regulation-7SK Tat stimulation provirus, Rev export incompletely MYC-repressed antagonize progression.The proto-oncogene MYC-regulated expands MYCLo-4, -5 -6 categories (downregulated MYC-expressing HCT116, RKO). MYCLos MYC-modulated cycle-related MYCLos, MYCLo-4 MYCLo-6. IPW DLK1-DIO3 Prader-Willi syndrome.Parental parent-of-origin (PWS), disorder, case-derived (iPSCs) 15. PWS-iPSCs parthenogenetic iPSCs, unexpectedly virtually (MEGs) 14. IPW, PWS iPSCs MEGs coincide ubiquitin-proteasome infection-inflammation preterm births premature rupture membranes. Dissecting nascent analysing content factories.While poly-adenylated routine, characterizing challenging, simple, fast cost-effective isolate factories, pro-inflammatory cytokine TNFα, analyse factories poly(A)(+) fractions factory transcriptome; (eRNAs), micro-RNA repeat-derived produce confer specifically-retained p50-associated COX-2 extragenic (PACER) occluding NF-κB complexes.Deregulated causally boundary/insulator CTCF establishes COX-2. Upon p50, NF-κB, occludes promoter, facilitating activation-competent p65/p50 dimers. p300 acetyltransferase, domain-wide Polymerase unexpected occlusion COX-2-lncRNA, PACER, COX-2-modulation cancer.DOI: http://dx.doi.org/10.7554/eLife.01776.001. porcine development.Long 55.02 90-bp paired-end assembled 54,550 cufflinks. 570 multi-exon conservation. isoforms (PRC2). CALML5 ZNF750- TINCR-induced stratifin differentiation.Outward progenitors hundreds identities microdissection calmodulin-like (CALML5) outer epidermis. ZNF750 stabilized TINCR. keratohyalin granules, Mass spectrometry SFN (stratifin/14-3-3σ) CALML5-binding suprabasal epidermis, cocontrols 13% partners. ZNF750-TINCR-CALML5-SFN unveils signature.Despite inarguable relating ChIP-seq p53-regulated p53-lncRNAs lowered constituting power. Comprehensive amplification.Long potent physiology, oncogenes suppressors focal copy-number alteration GENCODE adenocarcinoma, profiles. 10,419 407 subtypes OVAL, narrow weakly coincided OVAL Screening amplification, testable paves Uncovering "dark matter" uncharacterized matter," garnered grows, ongoing focusing enable enumeration partners determination positioned intervention biotechnology. CASC15 Involved Melanoma Progression Phenotype Switching.In implication (CNAs) nonprotein-coding cutaneous 6p22.3 15) segment actively specimens, predictors 141 (American Joint Committee Cancer) switching states. phenotypes. CRISPR-Cas9 complex.Systematic perturb generalizable structure-guided engineering loci. Cas9 single-guide (sgRNA) rules activation, multiplexed simultaneously, synthesized library 70,290 guides RefSeq BRAF inhibitor. sgRNA Cas9-based LncRNA-MAF:MAFB differentiation.Progenitor expression; remodeled (TFs) defined. kinetic regeneration epidermis (594 genes), (159 (387 genes). Module 1,046 TFs MAFB MAF:MAFB 393 ANCR TF controlled, GRHL3, PRDM1. Each loss, MAF:MAFB. lncRNA-TF region: pathogenesis.The manner, strands NcRNAs loci, 98 comprise piwi-interacting strictly controlled (14q32) DLK1, RTL1, DIO3 (Gtl2), MEG8 (RIAN), RTL1 (asRTL1). hosts, MEG8, 53 forward (mir-1247) strand. pathophysiologic domain-containing innovative expressed. Aging Subependymal Zone.The subependymal (SEZ) debatably neurogenesis multi-step requiring orchestrated state/fate transitions. adaptation, region-specific SEZ specialized birth adulthood aging emphasis age-related progenitor, SEZ, neurodevelopmental emerge birth. Bayesian network.Long built. enrichment. Application 762 assigned (e.g., development). inferred gene-based NALT NOTCH1 lymphoblastic leukemia.Long Location 100 bp CCK8 EDU stain. affection GSI. sorting side-population ALL companied NOTCH1. Gal4-λN/BoxB NOTCH blot. neighbor NOTCH1, Lnc-RP11-611D20.2 (named NALT) founding molecularly-directed MIAT: Myocardial infarction more.Non-coding myocardial infarction, retinopathy, schizophrenia, bodies, neurogenic commitment. utilization MIAT. SRP physiologically cotranslational targeting.The recognition particle (SRP) cotranslationally membranes ribosome-associated polypeptides membrane-associated receptor. GTP hydrolysis SRP-receptor govern GTPase-activating (GAPs) GTPases, trafficking viability. property tetraloop. tetraloop defective complexes, fail Tethered hydroxyl probing positioning GAP phylogenetically hereditary haemorrhagic telangiectasia.Hereditary Haemorrhagic Telangiectasia (HHT) dominantly mucocutaneous arteriovenous malformations visceral organs. HHT ENG ACVRL1, belong haploinsufficiency ACVRL1 manifestations sizable transcriptome, wanted manifestations. nasal telangiectasial non-telangiectasial design. v.16 4,810 2,811 (q&lt;0.001). GREAT, assumes cis-regulation, HHT. deserves possesses discovering Dlx jaw primordium jaw-specific upper programs.Dlx patterning jaw, nested branchial arch (primordium jaw) phenotypes; Dlx1 Dlx2 (Dlx1/2-/-) Dlx5/6(-/-) transformation jaw. 'Dlx codes' regionalize Dlx1/2 Dlx5/6 Towards Dlx5/6, mandibular (prospective jaw). unrecognized Dlx5/6-downstream mutant. Dlx-regulated Gbx2, Gbx2 Dlx5/6. Pou3f3 maxillary arch, Dlx5/6(-/-), arch-derived skeleton. comparative redundantly antagonistically arch. Dlx-mediated patterning. Bidirectional CAG intranuclear polyglutamine inclusions 8.We (CTG)n (SCA8), penetrance. (CTG)116 expansion, (CTG)11 neurological cerebellar-cortical 1C2-positive cerebellar Purkinje brainstem autopsy antiparallel (ataxin 8, ATXN8) spanning direction. BAC pathogenicity (CTG-CAG)n expansion. (CUG)n strand, ATXN8OS) toxic gain-of-function Beta-globin enhancer.Histone acetyltransferases elongating idea intertwined establishment beta-globin chromatin. H3 K4 TATA modifications, properties enhancer. HS2, gene: genic another. CTCF-binding silencer sequential tumourigenesis.We silent retaining (WT1 ARR). ARR repression, CTCF. Binding methylation-sensitive unmethylated silencer. Potentiation down, silencer-blocking nephrogenic rests. Nephrogenic rests foetal reductions residues spreading imprint erasure, Fine-scale genes.High-throughput (3D) reliance restriction DNase comprehensively contacts. fragmentation, efficiency Hi-C. Coupling DNA-capture fine-scale 3D 998 super-enhancers glimpse type-specific RNA-associated RNP step.Long remodelling, (treRNA) treRNA lymph-node downregulates ribonucleoprotein (RNP) (hnRNP K, FXR1, FXR2), PUF60 SF3B3, Translational Comparative primate reconstruction ancestral XIST locus.Here X-Inactivation Center (XIC) primates outgroup species. lemurs strepsirrhine sister reconstruct XIC itself. Reconstructed dramatic 80 years occurred Old World ancestor XIST-specific repeats; rather, reflects incremental identity insertions. reinforces change, Networks Transcriptomes Implicate Intellectual Disability.The advent diagnoses disability (ID), predisposing gap causal ID screening, identifiable focus genes; outnumber vastly ID-predisposing ID-associated list probands, prioritized probands. DEANR1 endoderm FOXA2 expression.Long specification. lineages differentiation-stage-specific endoderm-specific definitive endoderm-associated lncRNA1 (DEANR1), FOXA2. rescue by DEANR1 SMAD2/3 study not characterizes Topological multichromosomal Firre.RNA, matrix. identities, dynamics Firre, nuclear-matrix hnRNPU 156-bp repeating localizes ~5-Mb Firre trans-chromosomal reside colocalization chromosomes. stress-inducible cells.Whole Currently, approaches, 6,088,565 vertebrates, primates. ubiquitously. mitomycin doxorubicin, C- doxorubicin-treated agents, nomenclature RNAs.The cytosolic secretory organisms. SRP. gaining composition, assembly, phylogeny assist continuation divisions LncRNAWiki: harnessing community collaborative curation RNAs.Long diversity lncRNAWiki (http://lncrna.big.ac.cn), wiki-based platform open-content publicly editable community-based Current experts, making laborious exponentially accumulated inevitably collective Unlike databases, integration resources edited, curated users user. harnesses collecting, annotating rewards community-curated explicit authorship contributions. LncRNAWiki relies scientific up-to-date knowledgebase starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA protein-RNA CLIP-Seq data.Although (miRNAs), (e.g. pseudogenes circRNAs) cell-fate surprisingly v2.0 (http://starbase.sysu.edu.cn/) systematically RNA-RNA (PAR-CLIP, HITS-CLIP, iCLIP, CLASH) 37 analyzing millions sites, ∼9000 miRNA-circRNA, 000 miRNA-pseudogene 285,000 miRNA-mRNA date. ∼10,000 CLIP-supported annotations, miRFunction ceRNAFunction servers miRNA-mediated implementations visualization, downloading aforementioned expand Barr body: mosaic eXIST chromosome.During X-chromosome (XCI), entire permanently converted body, compensation eutherians sexes. XCI XIST, coats heterochromatin factors, silences During XCI, established, discuss facultative H3K27me3, H2AK119ub, macroH2A pericentric HP1, H3K9me3, H4K20me3. reinforcing domains. "Xplores" interact, gaps filled. periodontal ligament marrow.Mesenchymal anatomic activities. Maintaining depend diversity. restricted. (BMSCs) (PDLSCs) PDLSCs, 457) 513) BMSCs. 1,578 characteristics, Signal-net phospholipase beta 4, filamin beta, calcium/calmodulin-dependent gamma, ionotropic glutamate AMPA betweenness centrality coding-noncoding PDLSCs BMSCs chemokine (C-X-C motif) ligand species.To sub-types RNAfeature, &gt;600 epigenomic biophysical scores. RNAfeature utilizes fine-tuned intra-species wrapper considers region). structures, signals). canonical CDSs UTRs (accuracies: &gt;92% worm fly). instance, supervised 10-feature Arabidopsis (accuracy: 82%). identify, covers unconserved ncRNAs), tRNA, snRNA, miRNA, etc) ∼70% KLHL1 pathology.An unstable trinucleotide tracts. Spinocerebellar CTG untranslated, overlaps Kelch-like (KLHL1) Clinically, SCAs, truncal ataxia, ataxic dysarthria horizontal nystagmus, signs sizes etiology, pedigrees SCA Friedreich's parkinsonism. cerebellum. colocalized symptoms neuropathogenesis. cancer.Analysis (EV) contents diseased reliably summarize circulation, digital tumor-specific EV (SNHG12) angiomotin Angiomotin, AMOT SNHG12 detail (n = 20) (n = 20), SAOS-2, MG-63, U-2 OS, hFOB (OB3) angiomotin, AMOT. SNHG12. preliminary recommended accompanies colinear rises complexity organism, culminating 99% nonprotein transcribed, alleged paradox output scenario include clusters. "opposite transcription" spacer retinoic morphogen Opening Alternately cancer.Many well-characterized (WT) leukaemia (WT1-AS), spliceoforms parallel (ARR) displaying WT. Wt1-as. exported heteroduplexes WT1-AS, malignancy. RNA:RNA interactions, v7 RNAs: structure, expression.The compelling examples, analytical hampered annotation. date, consortium project 9277 manually producing 14,880 histone-modification signals, exon/intron lengths. two-exon nucleus, neutrally evolving sequences-particularly one-third arisen organs lncRNA.p53 globally (eRNA) production. p53-induced p53-binding not. dynamics, LED attenuates Chromatin-binding eRNA CDKN1A p53-responsive reduces promoter-associated tumours. layer Ox-LDL macrophage-derived foam expression.Atherosclerosis harmful health. oxidized low-density (Ox-LDL) atherogenesis adhere intima intimal macrophages intake scavenger receptors, Foam excessive atherosclerosis Ox-LDL-induced profiling. details quality uploaded (accession GSE54039). Pluripotency.Pluripotent (PSCs) kind cell, indefinitely self-renew germ layers. such, Embryonic Pluripotent (hiPSCs) earliest interest. exist balance multilineage Regulatory flavors: long. PSCs. pluripotency, emphasizing interplay Construction lncRNA-lncRNA actions (LFSNs) co-regulation coexpressed pairs, Applied LFSNs modular tend hubs LFSNs. proof-of-principle information. reprogramming.Embryonic maintenance, reprogramming remodelers, (RBPs) witnessed RBPs systems, systems. miR-545/374a Ftx progression.Hepatitis (HBV) (HCC). harbors miR-374b/421 HBV-HCC prognosis-related capsule. mimics HBV-genome-containing plasmid Bel-7402 monitoring sera excision, tumor-derived sharp days excision. gender-based miR-545/374a. estrogen-related gamma (ESRRG) miR-545 prognosis, transcriptome.Long 7,256 43 Tb ab initio methodology set, yielding consensus 91,013 Over 68% (58,648) 79% unannotated. About (597) harbored ultraconserved 7% (3,900) overlapped SNPs. prioritize lineage-specific, non-parametric 7,942 lineage- autism disorder.A (ASD). 3929 ASD leukocytes, 2407 1522 2591 (mRNAs), 1789 821 leukocytes. cycling, depression involved. Thirteen ASD. transportation cycling synaptosomal protein(s) presynaptic postsynaptic Finding bi-directional Discovery SHANK2-AS BDNF-AS, SHANK2 BDNF, ASD-causing opened avenue lncRNA(s) biomarker(s) Dlk1-Dio3 promotion.The nongenotoxic understood long-lasting phenobarbital (PB) Molecular (mRNA, [miRNA], proteins) weeks PB originating cluster, neoplasms glutamine synthetase-positive hypertrophic perivenous hepatocytes, carcinogenic androstane opportunities compounds. subtypes.Accumulating 658 infiltrating (non-transformed) MCF-7. prognoses. cis- trans-acting master HER2-enriched Estrogen IV. (i.e., H3K27ac), depicts subtype epigenome. higher-order arrays.The Snurf-Snrpn 100-200 repeated (sno)RNAs introns C/D snoRNAs derive envisaged, (at least) units. host-gene accumulate structurally constrained prevented diffusing, nucleoplasmic foci dispersed nucleolus. displays organization: identical, visualized singlet signals. repercussions intra-nuclear fate ventricular septal defect.Ventricular (VSD) congenital non-infectious nevertheless, VSD dynamics. VSD. VSD-affected second-generation (29,241 transcripts). 880 628 filtering ENST00000513542 RP11-473L15.2, furthermore, illustrates intricate background/reference iodothyronine deiodinase lines.Type (D1) (D2) catalyze prohormone T4 T3; (D3) catalyzes T3. D3 placenta, pregnant uterus, deiodinases Dlk1 Dio3os, D2 ECC-1 endometrium MCF-7 mammacarcinoma WRL-68 choriocarcinoma phorbol ester 12-O-tetradecanoylphorbol-13-acetate 2- 9-fold ECC-1, MCF-7, WRL-68, Estradiol 3-fold Dexamethasone serum. retinoids cAMP hormone. Dio3os D3-expressing type-specific. estradiol uterus Defining Proteome Transcriptomics Antibody-Based Focus Cerebral Cortex.The common, distributed, discretely transcriptomics (HPA) brain-enriched (frontal cortex) draft altogether 3% (n=571) (n=87) enriched, antibody-based micro astrocytes, oligodendrocytes Detailed multi-angle organ. FAS-antisense soluble Fas lymphoma.Impaired Fas-mediated Soluble (sFas), skipping sequestering ligand. sFas non-Hodgkin's (FAS-AS1). sFas, RBM5 RBM5-mediated skipping. lymphomas, hyper-methylates EZH2-mediated DZNeP (3-Deazaneplanocin A) overcome FAS-AS1, correspondingly sFas. Bruton's ibrutinib killing. NR_045623 NR_028291 benzene hematotoxicity occupationally benzene-exposed workers.Benzene hematotoxicant leukemogen. needed. hematologic Dynamic (NR_045623 NR_028291) subnets responses, hematopoiesis, leukemia. hematotoxicity. infer RNAs.As disorders accomplish Applying accuracy. non-tissue-specific 0.7645, 89%. codes http://asdcd.amss.ac.cn/MingXiLiu/lncRNA-disease.html. accelerated Huntington's disease.In (HD) REST. HD, (HAR1), cis-antisense HAR1 motifs, HD individuals. accompany Distinctive chimpanzee RNA.Human (HAR1) evolved divergence chimpanzee. neocortex. Employing panoply enzymatic probes, differing published. surprisingly, substitutions adopt cloverleaf-like sequence. profound metabolism.Long (PCGEM1) androgen-induced prostate-specific PCGEM1's (AR). PCGEM1 advantages aerobic glycolysis, coupling pentose phosphate shunt biosynthesis lipid, NADPH redox fatty biosynthesis, tricarboxylic PCGEM1-mediated takes place Significantly, transactivation PCGEM1-dependent coactivator AR, reprograms way, intervention. 13q14.3 Cis NF-kB.Non-coding thought. enigmatic. DLEU1 DLEU2 band recurrently 13q14.3, chromatin-immunoprecipitation DNA-demethylation semi-quantitative (aPRIMES, BioCOBRA, MCIp, MassARRAY, bisulfite sequencing). coregulation NF-kB dominant-negative blots antibodies, ELISA unbiased 810 miR-15/16 strongest inducers DNA-methylation NF-kB. underlines Whole axons.Most polarized sorted subcellularly amounts input optimized double-random priming serially diluted pg. Read counts replicates, scalable. sized &gt;300 bases. protocol 70% composition compartmentalized motoneurons. somatodendritic compartment post-synaptic 7SK. axons, 7SL. subcellular anatomically fiber PVT1: rising star RNAs.It critically (mis)function. maturity, resides 8q24. couple accidental conditions slowed is, preconception primacy oncogene. brought spotlight interesting functioning, oncogenes, advancements modelling questions unanswered precise functioning. SINEUPs unveiling biotechnological infancy. AS Uchl1, Ubiquitin carboxyl-terminal esterase L1 (Uchl1), UchL1 elements: inverted SINEB2 Uchl1-derived Uchl1 representative requirement UP-regulate Doman (BD) Effector Domain (ED). swapping BD, directed N-terminally tagged miniaturized design DJ-1 scalable reagents manufacturing haploinsufficiencies. differentiation.Long Less lineages. &gt;2000 cultures TH immunologic effector consists cytokines, IL-4, IL-5 IL-13. humans RAD50 contiguous (LCR) mouse. synteny TH2-LCR, refer TH2-LCR lncRNAdb reference RNAs.Despite eukaryotic lncRNAdb, http://lncrnadb.org, comprehensive, 287 literature. capturing describing user enabling accessibility information, Body BLAST easy download API. endorsed RNAcentral compliance Nucleotide Sequence Database Collaboration. follicular maturation ovulation.Cumulus ovulation. Knowledge rodent equivalent thoroughly unidentified. Compact (CCs) germinal (COCs) (IVM) procedures. Expanded CCs metaphase COC IVF/ICSI. Global state-of-the-art 1746 (DE) compact expanded CCs. movement, cell-to-cell interaction, steroidogenesis. DE 89 granulosa maturation. IVM Balanced hippocampal GABA circuitry.Genomic 2% Evf2 DLX5 forebrain. ventral forebrain, DLX MECP2 Dlx5, Dlx6 Gad1 GABAergic interneurons hippocampus dentate gyrus. returned hippocampus, occurred. proper GABA-dependent Castration-Resistant Cancer: Androgen Signaling Metabolism.Hormone-refractory relapses bone-metastatic cure. Understanding conferring deprivation castration-resistant (CRPC) Alterations CRPC. hyperactivity CRPC archetypes execute-as decoys, guides, scaffolds. archetype, disparate contexts illustrate commonality mechanisms, views explanations consider acquire transducers hint diversified. neurodevelopment, disease.Long cell. functionality tissue-restricted mode guide (if any) role(s) neurodevelopment Associations neurodevelopmental/neuropsychiatric Luminal ligand-independent cancer.Estrogen hormones hormone-independent estrogen-induced settings. 133 Apo-ERα-Regulated (AER-lncRNAs) biopsies. AER-lncRNAs subset, subtypes. AER-lncRNA, DSCAM-AS1, ERα+ pre-neoplastic EMT DSCAM-AS1 recapitulated, i.e. ERα-dependent Right failure.The (HF) (RNA-Seq), explanted HF unused hearts. Cufflinks DESeq cross-reference Ensembl (Genome Reference Consortium build 37) tools. hearts, 84,793 13,019 2,085 1,064 pseudogenes. categories, 7.7% 3.7% pseudogenes), 2.5% parent Exploratory silico roles. HF, RNAs.Non-coding matched-pair Initial tiling Sixteen CRIM1, EPAS1, ZEB2, RBMS1, RFX2. ZEB2 (EMT), deriving RFX2 EPAS1 morphology, morphology. Paired-end pointing underappreciated UM 9(5)h 9(5)p, preferential cerebellum.We Lower cerebrum, pituitary, intestine, liver. 2,273 nt 1,701 5'-truncated clone, codons frames. fragments, contig 2,336 Like stretches homology interrupted homology. single-copy distributions, fragment. Exploration Deregulated Hepatocarcinogenesis Survival.Long division, 65 90% Bonferroni correction comparisons. (6-7) Cancers 2015, 1848 (HR 8.5, 1.0-72.5). depicted 0.93 (likelihood (AUC 0.96, 87%, 87%). RNA.Proteins typify DNA- (DRBPs) features; conserved. Proteins independently. practice outdated, DNA-binding DRBPs maintenance. IC-SNURF-SNRPN serves UBE3A.The oppositely (IC) SNURF-SNRPN centromeric (MKRN3, MAGEL2, NDN, SNURF-SNRPN, HBII-13, HBII-85 HBII-52). HBII (snoRNA) (DMR). (UBE3A ATP10C), So maternal-only UBE3A indirectly starts IC. sense/UBE3A unit 460 148 HBII-52 (HBII-436, HBII-437, HBII-438A HBII-438B), Almost Northern neonatal celiac disease.Celiac immune-mediated component. 39 non-HLA proposed. scrutinize diagnosis/treatment) non-celiac groups, trans-eQTLs cis-eQTLs found, rs1018326 described, biopsy oversimplistic fine-tuning Imprinted DIRAS3 GNG12-AS1, RNA.Imprinted CCCTC (CTCF)-mediated boundaries, (also ARH1 NOEY1) RAS superfamily GTPases GNG12-AS1. GNG12-AS1 DIRAS3. variants, allele-specifically spliced. Cohesin imprinting, remaining monoallelic. DIRAS3, cotranscriptional CTCF-cohesin [Comparative mouse].After rodents, centers (XIC/Xic) directions. transposon constitutes 72%), LINEs, prevail center. contrary, repeats species-specific SIN Es 35%). chromosomes trasnsposons. XIST/Xist, TSIX/Tsix, JPX/Jpx, FTX/Ftx, ofmicroRNA originated L2 [1]. preserved 140 Myr ago, marsupials mammal Digital SnoRNAs, polyA-neutral amplification.Non-coding polyadenylation-neutral eleven U2, 7SK, exceeding H/ACA rRNA pseudouridylation, respectively: spleen both, hypothalamus snoRNAs, testes telomerase TERC. 14q 14q(I-6) members. align mitochondrial tRNAs. (group I) hypothalamus, III. 400,000 span ovaries. compendium richness function-specific Lessons imprinting.Genomic post-transcriptional-based article, overview (H19, MEG3), (Kcnq1ot1, Airn, Ube3a-ATS), (IG-DMR eRNAs) intra-chromosomal compartmentalization, timing positioning. collision-based neural-related plasticity. fine-tune action, uncovering contexts. Special Issue entitled: Clues taxonomy, edited Dr. Tetsuro Hirose Shinichi Nakagawa. molecularly necessitates So, SOX2OT, PTPRG-AS1, ANRASSF1, 38 (ANCTs). ANRASSF1 ANCTs. Her2/neu triple tumor.Wilms' heterozygosity 11p13, allelic occur, evident methylated, Southern heterozygosity-negative WTs kidneys hypomethylation Principles species.The inability echinoid sea urchin, species, &gt;70% traced homologs diverged &gt;50 5'-biased patches architectures rewired, exonization. tolerate p53-Regulated Protein, Revealed Pulsed Stable Isotope Labeling Amino Acids Culture (pSILAC) Next Generation (NGS) Analyses.We proteomics (pulsed isotope labeling culture/pSILAC) SW480. generation (RNA-, miR-Seq). (ChIP-Seq). (542 up, 569 down), (1258 415 (111 down) (270 123 down). 0.50, vicinity occupied (4.3% 7.2% 6.3% 5.9% (2.4% 3.2% 0.8% 1.9% proteins), Around 50% seed-matching 3'-UTRs. miR-34a. LINC01021, MDFI, ST14 miR-486 LINC01021 KLF12, HMGB1 CIT miR-205 miR-486-5p, omics p53-mediated Origin center.Random eutherian X-linked compensation, (Xic). abundance transcribing Xist, center, marsupial whilst starting material non-translated pre-existing mobile modeled started chromosome, Tsix, Jpx, Ftx. appearance Xic, marsupials, compensation. iPS neuropsychiatric disorders.Genome-wide Differentiating ideal abnormalities lie disorders. applying patient-specific neurons. Dramatic (SZ), bipolar (ASD) modifiers, POU3F2 ZNF804A, adhesion NRXN1 NLGN1. myelopoiesis. well. SZ NAGNAG RNA.NAGNAG adaptable operative (lincRNA). queried hypothesis. querying datasets, acceptors lncRNA-PCG bipartite cancer.LncRNAs remodeling, downregulate present. space proposing (PCGs) correlation, PCGs walk. LncRNADisease MNDR, seed nodes, ENSG00000234741 them. (ENSG00000225937 ENSG00000236830) ranked 30. ENSG00000261777 DDX19, IGF2 P1, method. hope bring lncRNA‑mRNA co‑expression infarction.Previous affymetrix re‑annotated, infarction‑related (MILMN) MILMN, lncRNA‑pathway disease‑associated dilated cardiomyopathy mitogen‑activated infarction. lncRNAs‑H19 predicted, signal‑regulating kinase, biomarkers, dissecting cancers.Despite deoxyribonucleic (DNA) 4629 705 reannotating 2461 subcategories, ubiquitously Network demethylated Encodes Peptide (CRNDEP) Which Overexpressed Highly Proliferating Tissues.CRNDE, lncRNA-coding gametogenesis, CRNDEP. methods, 84-amino ORF team. vectors, polyclonal immunohistochemical, CRNDEP transient shRNA-mediated CRNDE. proliferating parabasal epithelium, crypts spermatocytes. artificial EGFP DsRed Monomer tag, granules localize Possibly, oxygen considering enforced granules. lines.Data Elements (ENCODE) 9640 ~100 deeply jointly project: tandem mass (MS/MS) peptides polyA+ polyA- GM12878. machine-learning RuleFit3 regress covariate was, Cytosol ~13-fold ~92% Intersecting 79,333 matching 69 misannotated exceptions pseudogene compromised codons. translatable ORFs match, false-positive matches. exceptions, ribosomes hence, lncRNAome. Evidence influenza replication.A focus. force, NCode™ Sureprint™ G3, (IAV) inducible (VIN), IAV strains (H1N1, H3N2, H7N7) vesicular stomatitis virus. observe VIN virus, mimics, IFNβ. infections. RNA-FISH nucleus. abolition highlighting pathogens guaranteeing propagation, virulence. detail, antiviral host's triplets cancer.Recent lncRNA-miRNA-gene (LncACTs), lncACTs non-competing lncACT coding-genes topological competence sub-networks H19- BRCA1/2-associated Disease-associated HuD APP→Aβ processing.The learning memory. (encoding protein) β-site APP-cleaving half-lives (lnc)RNA BACE1AS, complements enzyme, APP, Aβ HuD-overexpressing mice. (superior gyrus) accordingly, age-matched amyloidogenic Aβ. Deciphering 8q24.21 glioma.We tagSNPs sought fine-map location 4147 7435 700 imputed high-coverage 253 low-frequency rs55705857 2.24 × 10(-38)) non-glioblastoma multiforme (non-GBM) 1.07 10(-67)). non-GBM (625 cases, 2412 1.41 10(-28)). pooled low-grade 4.3 2.31 10(-94)). evolutionarily raising functionality. aetiological peptide-coding parallels UTRs.Recent individually debated. proven created culled Database, 204 valadkhanlab.org/database. codon contexts, nonsense-mediated peptides. similarities (3' UTRs) composition. UTRs, constraints Dio3 brown adipocytes.Active (D3), inactivates coded Dio3, preadipocytes adipocytes. Dlk1, adipocyte Dio3. 4-kb Dlk1/Dio3 Ab lincRNAs.Massively depended crucially annotations Scripture, manipulation render picture transcriptomes. system.All program biogenesis, versatile progressing Dicer-dependent turnover eukaryotes evident. activation-linked models. Dicer-deficient (RNAi)-related RNAi-dependent centromeres. X-rays-treated lymphoblastoid cells.A (ncRNA), (snoRNAs), PIWI-interacting (piRNAs) recovering radiation-induced positive) WTK1 negative) SNHG1, SNHG6, repressed. SNHG7 SRA1 only. PIWIL1 radiation-treated Stability, sperm fertilization.Increasing sperm, child, flux, assigning challenge. population sperm. Examining preparation stage-dependent illuminating transitional post-fertilization CARs, pri-miRNAs, abundance, unfertilized oocyte, attributes spermatozoal Meta-analysis Genome-Wide Extraversion: Findings Genetics Personality Consortium.Extraversion personality psychosocial, lifestyle heritability, (GWA) GWA extraversion 63,030 cohorts. Extraversion item inventories harmonized (SNP) hit (LOC101928162). variance explained zero, linkage cohort. trait, traits, Future modes extraversion. U19 intron-encoded coding.While originally "genetic junk." pre-mRNAs UHG snoRNA, U19H Splicing molecules. sole snoRNA. dogmatic view, anticipated. Tag profiling.Profiling microRNA, microarray-based create compendia instances, pursued. tags (ESTs) incomplete. ESTs Beyond immune-enriched cross-validation Immunogene EST road PRDM15 deconstruction physiologic PinX1 screening.As nontumorigenic knocked-down 977 631 sites.p53 execute members, (ChIP-seq) searched motifs peaks, assumed family. miR-190a treRNA.treRNA post-transcriptionally. Suppression mesenchymal-epithelial capability miR-190a-treRNA 45,X fibroblast Turner syndrome.Turner females. aneuploidy condition gonadal dysfunction, stature, mellitus, others. Haploinsufficiency untransformed 46,XX karyotypes. monosomic mechanism(s) implications.Long kinds 150 306 stimulus. results. α (Kaplan-Meier) atrial fibrillation.To fibrillation (AF), AF non-AF AF. AF-related 219 AFs 156 uc001eqh.1 RP5-833A20.1/miR-382-5p/NFIA-dependent transduction LUCA-15-encoded CD95-mediated apoptosis.Using 326 bp (termed Je2) suppresses, Jurkat Je2 3p21.3, TSG LUCA-15 represents, fact, Clone 26), cancer.For decades Vogelstein's overt simplistic denominated [i.e., circular RNAs] profoundly vision genetics pathobiology. exploiting apoptosis: sophisticated dictates correct Different neoplastic properties. attractive secreted environment fluids): pathology. issues pathobiology Clinical Relevance Cancer.Non-coding discovery, &gt;200 potential, modestly setting, validity compartments fluids Constructing similarity.Increasing plenty fields identification. effort attempted assumption calculation (LNCSIM). LNCSIM Laplacian Regularized Least Squares (LRLSLDA) prediction. LRLSLDA risk.Long evolutionally biologically functional. phenotype-related intervals. single-nucleotide PCa polymorphic 1998 GWAS, intervals 5-fold rs3787016 19q13 (per 1.19; 1.11-1.27) 7.22 10(-7). interpreting rearrangements FRA2H fragile non-homologous recombination LTR L1(LINE) repeats.Common (cFSs) non-random prone breakage cFSs cFS instability, characterised. fine-mapped six-colour hybridisation encompasses 530 gene-poor (AC097500.2). hybridisation, gross submicroscopic terminal interspersed microhomology-mediated Identifying accelerate individualised Aberration Biomarker Esophageal Carcinoma.Esophageal Eastern countries. Unambiguous summarizes ncRNA-mediated behaviors strategies. non-trivial: lincRNAs.Long mysterious applications, surge research, advancement predictions, comprehensively. Single-Cell Preimplantation Embryos Newly Reprogrammed Female Induced Cells.The (XCI) (iPSCs), programming preimplantation well-understood. Indeed, oocyte-to-embryo reprogrammed iPSCs. 4-cell coincident asynchronous transcript; NRAV, interferon-stimulated transcription.Long immunity. call (NRAV) viruses, ectopically NRAV production, (ISGs), IFITM3 MxA, interferon increase.'Gain' supernumerary myelocytomatosis (MYC) co-gained 'gene desert' 2 megabases GSDMC Whether known. Myc encompassing Pvt1, Ccdc26 Gsdmc fails advance measurably, 8q24-amplified tumours, co-increased 98% MYC-copy-increase Ablation MYC-driven potency. refractory small-molecule inhibition, EMX2 mouse.The 10q26. EMX2OS strand), orthologous Emx2os. varying Neither frame, postmenopausal endometrium, absent EMX2, EMX2OS, Emx2os Conservation presumably EMX2. SET1A Cooperates CUDR Promote Hepatocyte-like Malignant Transformation Epigenetically.Long cooperates hepatocyte-like RB1, C-myc pRB1. cushion link pRB1, pRB1-SET1A hand, carry methyls(me) occupy H3K4, (H3K4me3). H3K4me3 loads TRF2 Ultimately, prolonging epigenetically. LncRNA-HIT Functions Regulator Chondrogenesis Recruitment p100/CBP Complexes.Gene E LNCRNA-HIT mesenchyme, gut, genital tubercle. forming p100 CBP. LncRNA-HIT-p100/CBP ChIRP-seq Ontological contacted LncRNA-HIT-associated treatments impacted mesenchyme condensation nodules. Mechanistically pro-chondrogenic H3K27ac mesenchyme. SOX2OT-S1, SOX2OT-S2 coupregulated SOX2 OCT4 (SOX2OT). processes; OCT4, NTERA2 (NT2), OCT4. coupregulation margin (SOX2OT-S1 SOX2OT-S2) ESCCs. Suppressing 5.9 6.9 sub-G1 SOX2OT-S1 SOX2OT-S2, diminished, neural NT2 susceptibility, next?Genome-wide (GWASs) meta-analyses informed 100 (RA). autoimmune realise investment RA-associated finds NFAT.Noncoding Yet, spite apparent ncRNA, projected arrayed (shRNAs) 512 begun (NFAT), importin-beta trafficking. Multidrug-Resistance Related Cancer.The (MDR). SGC7901, subjected verification MDR. "system development" "sterol biosynthetic process". sublines worthwhile Co-expression Genes.We associations. 1,865 Known compiled Catalogue Somatic Mutations UniProt depth. Hub DLK1-GTL2 rhabdomyosarcomas.Parental Rhabdomyosarcoma (RMS) soft-tissue sarcoma parentally reported, RMS (LOI) IGF2-H19 (IGF2) chromosomes, RMS. rhabdomyosarcomas (ERMS ARMS, respectively) LOI varies ERMS ARMS erasure (EOI) GTL2/DLK1 ERMS. (lnc-RNAs) vivo.Hyperactive castrate Yang lnc-RNAs PRNCR1 PCAT8) PCGEM1, ligand-dependent cells.1 acetylated DOT1L, terminus, DOT1L. autistic brain.The converge reconciling heterogeneity governed Yet ASD, 30,000 postmortem prefrontal cerebellum psychiatric homogeneity. RNA: failure?One discoveries post-genomic era transcribes (ncRNA). short/small ncRNAs--examples (miRNAs)--whereas Not field. Pulmonary agenesis: ipsilateral malformations.Pulmonary agenesis malformation anomalies. interested child agenesis, unlobed left lung, bilateral cleft lip palate, hypoplasia, microtia, radial ray horseshoe anomalies hemifacial microsomia. involvement. Children's face ray. unclear, aortic arches MiRNA-192 [corrected] miRNA-204 Directly Suppress Interrupt GLS1-Mediated Glutaminolysis Carcinoma.Accumulated deadliest miR-192 miR-204 Argonaute (AGO2)-mediated notion, miR-192, siRNAs antagonizing (multiple HOXA13), glutaminase (GLS1) miR-192/-204-HOTTIP glutaminolysis silencingGLS1, speculate interrupt GLS1 implications. tissue.The is emerging evidence, adequate normalisers, potential lncRNA tissue samples. (cortex, matter, cerebellum) Bioinformatical algorithm. suitable normalisers studies comparing (LUST, IGF2AS (family), HOXA6as, NDM29) (PMI) levels of identified 5 lncRNA normalisers PMI 27 h. 5 lncRNAs PMI, of highly Epigenetics Epilepsy.Epigenetic lasting epigenetics epilepsy epileptogenesis avenues hypermethylation, epileptogenesis. Posttranscriptional histones, sustained excitability seizure thresholds, manipulate epilepsy. men.Age-adjusted African-American men ancestry. men. Ghana Study. multivariable age ancestry 474 458 HumanOmni-5 Quad BeadChip. 10p14 RP11-543F8.2) 360 kb GATA3 (p = 1.29E-7). sub-analyses, 5q31.3 Gleason (≥7) missense PCDHA1 (rs34575154, p = 3.66E-8), Xq28 (rs985081, p = 8.66E-9) 6q21 (rs2185710, p = 5.95E-8) (&lt;7) Ancestry Consortium, SNP, 10p14, p &lt; 0.05. European, ancestry, Study, X-reactivation: reproduction cells.X-chromosome Chromosome-wide germline, meiotic inactivation, chromosome-wide spermatids embryos. embryos, X-chromosome, germlines. males dissected reactivated inner blastocysts allow embryo, Xs chance inactivated. X-reactivation naive ground pluripotency. osteoarthritic synoviocytes miR-770.Long Various synoviocytes; synoviocytes. Exogenous autophagy, miR-770. miR-770 co-introduction PCGEM1. proliferation/apoptosis actin-binding (KLHL1).Spinocerebellar SCA8, 166 repeat. orientation. arrangement 748 actin-organizing Kelch (KLHL1). KLHLI conserved, cerebellum, SCA8. epitope-tagged organizing cytoskeleton Pan-cancer function.A gene-centric highlighted type. pan-cancer ∼ 3,000 229 outlier 'onco-lncRNAs'. Due hypothesize onco-lncRNAs onco-lncRNA-3 onco-lncRNA-12, state.X-chromosome entails chromatin-modifications, DNA-methylation. (XCR) germline. Critical XCR multigene including, prominently, Xist Tsix. sit hierarchy, naïve point-of-view latest X-chromosome. multifactorial ensuring Pervasive RNAs.Known compose 97% uncharted territory, territory covering corroborating helping discrepancy prior noise. trait-associated Ifng Tmevpg1 T-bet.Long integrates (NeST, Ifng-AS1) Th1-lineage-specific Ifng. enhancers, stimulus-inducible Ets-1, Activities Tmevpg1-specific NF-κB. Ifng-specific 1000Genomes imputation cancer.Genome-wide far. (totalling 7,577 9,979 ancestry), imputing utilising Project. 1p36.2 rs72647484 (minor [MAF] = 0.09) CDC42 WNT4 (P = 1.21 × 10(-8), [OR] = 1.21 ) 16q24.1 rs16941835 (MAF = 0.21, P = 5.06 × 10(-8); OR = 1.15) RP11-58A18.1 ~500 kb nearest FOXL1. Additionally 10p13 rs10904849 CUBN (MAF = 0.32, P = 7.01 × 10(-8); OR = 1.14). exploit disease-causing High-resolution Gtl2-Dnchc1 12.The 1.1-Mb Gtl2 Ppp2r5c Dnchc1 transcript(s) Gtl2, Rian, Mirg. transcript(s), nonimprinted Enrichment Stem-Like s-SHIP Promoter Uncovers Stemness H19.Understanding stem-like immortalized RWPE-1. (GFP) stem-SH2-domain-containing 5'-inositol phosphatase) cell-specific shown. s-SHIP-GFP-expressing RWPE-1 (CD44, CD166, TROP2) (Oct4, Sox2), sphere-forming arsenite-induced Concomitant prompted oncofetal Targeted Oct4 Sox2 colony-forming s-SHIP-GFP H19. 12qF1 cells.Induced controversial blastocyst-derived indistinguishable exception 12qF1, iPSC chimaeras iPSC-derived animals ('all-iPSC mice'). viable all-iPSC clone deacetylase full-term prospective 8q24 segments NSMCE2 myelogenous leukemia.The pathogenetic leukemic minute verified. amplicons AML-derived HL60 namely, PVT1-NSMCE2 BF104016-NSMCE2. chimeric as-yet-unknown relapse. measuring decade, suppression; issue, tools, (KEGG), Metastasis deaths, dormant residual disseminated (DTC) ANKRD30A, immunotherapy, DTC LINC00993 ANKRD30A. Sardinians runs homozygosity selection.The peculiar Sardinia Mediterranean biogeographical isolate. estimate Runs Homozygosity selection, 1.2 1077 Sardinian methods--fixation index, inflation principal estimation--we highlight, expected isolate, homogeneity island. covered RoHs&gt;0.5 (F(RoH%0.5)) peninsular Italians, Alghero. re-captured TMEM252, forces. Microprocessor termination hosting microRNAs.MicroRNAs Mammalian minority originate uncharacterized. show, liver-specific lnc-pri-miR-122 (lnc-pri-miRNAs) cleavage-and-polyadenylation terminate readthrough lnc-pri-miRNA Consequently III-mediated, polyadenylation-independent locus.The G(s). deficiency G(s)alpha, G(s), hormone-resistance 1a. (and GNAS1) Transcripts Nesp55, P2 Xlalphas P3 (Mus spretus C57BL/6) P1 (pons medulla) P3. P1-P2 2.2 P1-antisense (Gnas-as) Nesp55 Gnas-as adrenal, spleen, negligible. Gnas-as. Gnas-as, [Long control].Studies hotspot as: cis-/trans-action baits nucleus; mRNA; 3) competitors microRNA; 4) application. homologous (IPW) gene.The (PWS) inactivate imprinted, 15q11-q13. PWS, polypeptide, Ipw, 7. Ipw 147 repeat, head-to-tail orientation, insertion intracisternal interspecies (M.musculus M.m.castaneus) F1 hybrid animal, IPW. subdomains locus.Gene hyperacetylate access; large, hyperacetylated DNase-sensitive RNA-pol modification. divided subdomains. transitions remodeling. initiates neurogenesis.Long rhabdomyosarcoma 2-associated (RMST), REST, coregulate pool coregulator metastasis: orchestrating EMT-MET decision.Long microRNA(miRNA) miR-675, it, (MET). seemingly scheme H19/miR-675 Demonstration multistep complex: catalytic RNA.Two (SR) endoplasmic membrane. 4.5S 400-fold. energy transfer, SR steps: GTP-independent GTP-dependent conformational intermediate. mutational stabilizing intermediate, probability rearrange coherent explains human-induced cells.In toxicological assessment: (hiPSCs). hiPSCs capabilities types, ethical (CDKN2B-AS1, MIR22HG, GABPB1-AS1, FLJ33630, LINC0541471_v2) stresses (cycloheximide, hydrogen peroxide, cadmium, arsenic) hiPSCs. p53-related Mining accumbens heroin abusers.Although organelle fortuitously Twenty-three accumbens. abusers drug-free subjects, consonant abuse. sixth nt, subpopulation (microRNAs), Investigating opens editorial (MALAT-1 RNA) known, delineated. (siRNA-mediated changing structure) Prostate-specific aptamer: antibody-like detection.We single-stranded 277-nt PCA3 PCA3-277 aptamer ligands obtained, molecule, CG3, Aiming utility, apta-qPCR CG3-aptamer conjugated beads 97-fold 7-fold Histopathologic biopsies TMA biotin-labeled hyperplasia (BPH) (78% cases). apta-qPCR, recognizes tool. 8.Microsatellite dominantly-inherited Expansions coding-regions effects, MBNL CELF Bi-directional (CUG(exp)) ATXN8OS pure ATXN8 CAG(exp) SCA8: CUG(exp) ribonuclear co-localize MBNL1 brain; Mbnl1 deficits mice; CUGBP1-MBNL1 GABA-A transporter (GAT4/Gabt4). optical Gabt4 granular layer. dysregulate MBNL/CELF homozygous LINC00237 MOMO (macrosomia, obesity, macrocephaly, abnormalities) syndrome.Macrosomia, (MOMO syndrome) sporadic clinical, cytogenetic, consanguineous parents suffering syndrome. Conventional (16;20)(q21;p11.2). Uniparental disomy bi-parental 20. patient's oligonucleotide array-comparative abnormality. (16;20)(q21;p11.2), strategy, 16q21 20p11.2 breakpoints, 20p11.23. LINC00237, HUGO (Human Organization) nomenclature. notably recessive hyperphagia-related obesity disability. embryogenesis.Activation (PAR-1) thrombin atherosclerosis, -4.2 -3.2 4.1 2.9 LacZ transgene veins. (ncR-uPAR:noncoding PAR-1) -3.4 kb. ncR-uPAR PAR-1-core promoter-driven II-dependent trans, albeit addiction SAMMSON.Focal amplifications 3p13-3p14 10% melanomas melanoma-specific MITF epicentre amplicon. amplicon melanomagenesis SAMMSON MITF. SOX10 melanomas. clonogenic drastically irrespective NRAS TP53 MAPK-targeting p32, cancer-cell-specific manner; deliver anti-melanoma LncRNADisease: long-non-coding diseases.In (LncRNADisease), accessible http://cmbi.bjmu.edu.cn/lncrnadisease. dysfunctions purpose, beneficial. 480 entries 478 description entry. 1564 leukemia.Genetic plethora stand defect, leukemias, CUTLL1 RNA-sequencing. Similar thymic (array data) CD4(+)CD8(+) thymocytes Integration Notch1 ChIP-sequencing pave 